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ABSTRACT
In recent years mass spectrometry has become an invaluable tool to address an
array of biological questions. The versatility of this experimental approach does not only
allow assignment of protein identity and identification of sequence specific modifications,
but with the help of particular derivatization techniques facilitates the determination of
peptide quantity. Each of these approaches were applied to the following biological
projects:
The 21 kDa heat stable protein purified from the encysted embryo of Artemia
franciscana was characterized by time-of-flight mass spectrometry. De novo sequencing
of peptides identified this protein as a group 1 Late embryogenesis abundant (LEA)
protein. The amino acid sequence assignment to these peptides allowed amplification of
the entire gene sequence from an embryonic cDNA library. This was deposited into the
NCBI database (EF656614). The expression of group 1 LEA protein is consistent with
and supports a role in desiccation tolerance. In addition, this is a first report describing
identification of a group 1 LEA protein in an animal species.
A MS-based quantitative analysis was performed in order to analyze relative
changes in the dynamic thiol and disulfide states of the redox sensitive protein disulfide
isomerase, PDI. PDI cysteine residues were derivatized with an isotope-coded affinity tag
(ICAT), thus allowing a direct comparison between the reduced and auto-oxidized forms.
Quantitation was based on relative ratios between light and heavy isotopically labeled
cysteine containing peptides. The application of the ICAT-labeling approach to PDI
related studies, allowed direct assignment of individual cysteine residues and their
oxidation status, compared to the previously employed techniques, that only provided

vii

information regarding the average number of modified cysteine residues within PDI, not
their exact identity.
A combination of a phosphopeptide enrichment step and a MS-based approach
was utilized to identify three phosphorylation sites on hYVHl, an atypical dual
specificity phosphatase that functions as a cell survival factor. With the help of
phosphomimetic and non-phosphorylable mutants, we were able to decipher their effect
on localization and progression through the cell cycle.
Collectively, these studies manifest the power of MS-generated data to influence
and guide many different fields ranging from molecular embryology to biochemistry.
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CHAPTER 1

Literature Review

1

Recent advances in mass spectrometry have brought this technique to the forefront
of discovery based system biology research. Since a major theme of this dissertation is
the application of different mass spectrometry based approaches to answer significant
biological questions, an overview of several different mass spectrometry based
approaches will be discussed, including methods employed during this dissertation.

ABC's of mass spectrometry
Mass spectrometry (MS) in recent years has become a fundamental experimental
approach in biochemistry. Mass spectrometers by definition measure mass-to-charge ratio
(m/z) of ionized analytes (Figure 1) [1]. A mass spectrometer is characterized by three
major components, an ion source, a mass analyzer and an ion detector (Figure 2A).
Originally, MS was restricted to measurement and analysis of small and
thermostable molecules, because large organic molecules (such as peptides and proteins)
would undergo extensive fragmentation and decomposition upon vaporization into the gas
phase [2]. This was overcome by the development of "soft" ionization methods (where
ions are created with low internal energy and thus undergo limited fragmentation), such
as electrospray ionization (ESI) [2] and matrix assisted laser desorption/ionization
(MALDI) [3]. These two ionization methods are fundamentally different. In the case of
ESI, a liquid sample is injected through a needle and the surface of the emerging liquid is
charged by an electric field, thus forcing it into a fine spray of charged droplets [2],
thereby producing a continuous beam of ions (Figure 2B) [4]. In the case of MALDI, the
gas phase ions are produced from a dry co-crystallized liquid sample with an organic
matrix [3]. The energy from the laser is deposited into the matrix causing rapid thermal
heating and thus generation of ions of the analyte molecules in a gas phase [3], thereby
2
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Figure 1. A simplified version of a Mass spectrometry (MS) experiment
A protein sample is prepared by an appropriate purification protocol dependent on both,
the type of biological question being asked, and the sample source (e.g. cultured cells,
bacterially purified protein or tissue samples). The sample is then subjected to enzymatic
proteolysis by common proteases such as trypsin, GluC, Lys-C and Asp-N. Generated
peptides are then ionized by electrospray ionization (ESI) or matrix-assisted laser
desorption/ionization (MALDI) for subsequent analysis by the mass spectrometer.
Ionized peptides are detected in MS mode as a peptide fingerprint and the MS/MS mode
provides information regarding the amino acid sequence of a particular peptide.
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Figure 2. Basics of peptide ionization and time-of-flight instruments
(A) The three major components of a mass spectrometer. (B) A schematic depiction of
the ionization process in a typical electrospray instrument, ESI. (C) A schematic
depiction of the ionization process by matrix-assisted laser desorption/ionization,
MALDI. (D) A simplified schematic of a MALDI time-of-flight (TOF) instrument. The
ions are first accelerated to high kinetic energy allowing separation based on their
different velocities along the flight tube. The detector amplifies and records arriving ions.
(E) A simplified schematic of a MALDI TOF/TOF instrument. A collision cell has been
incorporated between the two TOF sections.
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producing packets of ions (Figure 2C) [4]. Another common distinction for peptide
analysis is that mainly singly charged ions are generated upon MALDI, whereas ESI
generates multiply charged species [5].
There are currently four basic types of mass analyzers for the study of peptides
and proteins; time-of-flight (TOF), ion trap, quadrupole and Fourier transform ioncyclotron (FTICR) [1, 6, 7]. The separation of ions in these mass analyzers is based on
flight time (TOF instruments), stability (quadrupoles) and resonance frequency (ion traps,
orbitraps, FTICR instruments) [5]. Each analyzer has a characteristic behaviour with
regards to resolving power, sensitivity and dynamic range. In a quest to make the
analyzers better and more versatile, a new generation of 'hybrid' instruments have been
introduced. These instruments containing a parallel configuration of more than one
analyzer, can be either identical, as in case of TOF-TOF, or different as for examples in
quadrupole TOF, linear ion trap-orbitrap, etc. [1, 5, 6, 8]. The detector, the last but not the
least important part of the mass spectrometer, monitors voltage pulses and converts these
into a signal. This signal represents an ion intensity for a particular m/z and is displayed
as mass spectra [7]. As the work described in this dissertation was performed on MALDITOF and MALDI-TOF/TOF mass spectrometers, only these instruments will be
described in further details.
In the TOF instrument, the m/z is determined from flight times of peptides
through a tube of specified length under vacuum. This measures the mass of intact
peptides, which have been generated from intact proteins by enzymatic proteolysis prior
to analysis. The major difference between the MALDI-TOF (Figure 2D) and MALDITOF/TOF instrument (Figure 2E) is in how the information regarding the amino acid
sequence (MS/MS) of a specific peptide is generated. In a MALDI-TOF instrument, the
5

primary sequence analysis can be obtained by a process called post-source-decay (PSD),
which is based on metastable fragmentation. PSD can be observed when the reflecting
electrical field (reflectron) is placed at the end of the flight tube [9]. Upon selection of the
parental ion [MH]+ for analysis, a MALDI-PSD spectrum is obtained as a stitch of
manually acquired spectra corresponding to different portions of the peptide under
investigation (from the parental ion to the immonium ions) in a form of windows. Each
window (correlates to a part of the spectra) corresponds to gradual changes in reflectron
voltages [9]. A more common method to induce fragmentation for MS/MS analysis is
collision-induced dissociation (CID), which is based on multiple collisions between a
peptide under study with inert gas atoms [10]. The MALDI TOF-TOF instrument
contains a collision cell between two TOF sections (Figure 2E). Upon selection of the
parental ion [MH]+ the entire MS/MS spectrum is automatically acquired.
The MS/MS spectrum of a peptide precursor ion allows the assignment of an
amino acid sequence. As the amide bond is the lowest energy bond in peptides, this is
where most of the fragmentations will occur, thus generating y-ions (C-terminal fragment
ions) and b-ions (N-terminal fragment ions) (Figure 3A) [7]. Additionally, internal
fragments due to double cleavage of peptide bond may also be observed [7].

Mass spectrometry and biological questions
Biological mass spectrometry mainly focuses on the complex world of proteins.
This diversity is not only due to the fact that a particular gene can give rise to multiple
distinct proteins as a result of alternative splicing or that some proteins can differ in a few
amino acids due to sequence polymorphisms, but it is also a reflection of the vast array of
post-translational modifications that cause further complexity; such as phosphorylation,
6
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Figure 3. The ABC's of peptide sequencing
(A) Within the MS-instrument, the bond breakage mainly occurs at the amide bond, the
lowest energy bond. If the charge is retained by the amino-terminal fragment, b-ions are
formed and detected; if the charge is retained by the carboxy-terminal fragment, y-ions
are formed and detected. (B) Derivatization of a peptide by chemically assisted
fragmentation (CAF). CAF reagent introduces a negatively charged group to the aminoterminus of tryptic peptides, thus only y-ions will be detected in positive ion mode.
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glycosylation and ubiquitination just to mention a few. The changes in post-translational
modifications can be either analyzed conceptually for the entire proteome (proteomics) or
for a single protein. This will be described later.
With the advancement of the instrumentation and analysis software, one could
now answer questions like what proteins are present within the yeast 80S ribosome [11],
what dynamic changes in the complex composition does the pre-60S ribosome undergo
[12] and what proteins are residents in which mammalian organelle [13]? These are a just
few examples of the many proteomics studies reported in the last ten years. One
limitation of this technology is the under-representation of low abundance proteins.
Furthermore, as MS-based identifications rely on the detection of peptides, additional
factors must be considered including that some peptides might be too small or too large to
be detected, not all peptides are ionized efficiently and some might saturate the detector
[14]. In order to lessen experimental bias due to the presence and ionization of high
abundance peptides, a selected reaction monitoring (SRM)-based MS has been recently
implemented [15-17]. In this experimental approach, the parameters for MS/MS data
acquisition are pre-set, so that the instrument will only record three to five unique
proteotypic peptides for each protein, if these correspond to calculated y-ion series under
two main charge states. Furthermore, in a multiple reaction monitoring (MRM)-based
MS, multiple peptides can be targeted in a single experiment by repeatedly cycling
through a list of SRM-ion pairs associated with a set of specific retention times [18].
One of the major forces enabling proteomic analyses was the completion of entire
genome sequences for numerous organisms. These allow comparison between acquired
MS and MS/MS spectra with theoretically calculated fragment sizes from the in-silico
digest of a protein sequence in the databases. This is feasible because proteases
8

commonly used to digest proteins into peptide are sequence specific, for example trypsin
only cleaves C-terminal to lysine and arginine residues.
However, to date, not all of the organisms have their genomes sequenced and not
all of the proteins sequences have been deposited into databases. As the annotations of
MS/MS spectra containing y- and b-ions without prior sequence information are
challenging, simplifications of the spectra can be achieved by chemical derivatization (so
called chemically assisted fragmentation, CAF) [19, 20]. This method allowing de novo
sequencing is based on attachment of sulfonic acid to the N-terminus of each peptide
(+136 Da), which promotes an efficient charge-site initiated cleavage of peptide amide
bonds, and thus enables selective detection of a single series of fragment ions, the Cterminal y-ions (Figure 3B) [19, 20]. A step to protect lysine side chains from sulfo nation
includes conversion to homoarginine (+42 Da) [20].
One of the organisms for which the genome has not been sequenced yet is the
brine shrimp Artemia franciscana. In collaboration with Dr. A. Warner, Department of
Biological Sciences, University of Windsor we employed a MS-based approach to
identify a novel protein from this species. A heat-stable protein was purified from
encysted A. franciscana embryos and identified from peptide fragments by CAF
derivatization combined with de novo sequencing. This study will be discussed in detail
in Chapter 2 of this thesis.

Biological mass spectrometry and sample complexity
The complexity of peptide samples can be decreased by an array of separation
techniques. Peptides generated from proteins digested in solution (the "bottom-up"
approach, [1] can be fractionated by multidimensional chromatography called MudPIT,
9

where the first separation is based on charge (strong cation exchanger) and the second on
hydrophobicity (reverse-phase) prior to direct injection into the electrospray based MSinstruments (Figure 4A) [11,21].
Alternatively, instead of decreasing complexity of peptide samples by
chromatographic separation, proteins can be first separated on one-dimensional (ID) or
two-dimensional (2D) SDS-PAGE prior to enzymatic digestion into peptides. This allows
identification by either MALDI or ESI-MS (Figure 4B).
An elegant protocol based on the use of tandem affinity purification (TAP) tags
allows co-purification of interacting partners at substoichiometric levels [22]. Originally
this method included an SDS-PAGE separation of the protein components of the
immunoprecipitated complex and the collection of unique protein bands allowing separate
proteolytic digests to be performed. Overall, this decreased the complexity of analyzed
peptide samples [22]. The classical route for identifying interacting partners involves
over-expression systems, that usually employ genetically engineered fusion proteins
containing one tag, for example Flag-tag, Myc-tag, etc. These tags allow affinity
purification and/or detection, when a suitable antibody directed against endogenous
protein is not available, or not suitable for these applications. However, the ability to
detect fusion proteins at low concentrations in a complex mixture in these one-tag overexpression systems is limited. This problem was circumvented by the introduction of two
different tags (the TAP-tag system) separated by a protease recognition sequence (tev) in
frame with the protein for which the goal is to identify interacting partners (Figure 4C).
After expression of this fusion protein, the first purification step is based on the affinity
between IgG -binding domain (the first tag) and the IgG beads. Upon removal of nonspecific proteins by washing steps, the fusion protein is released from the beads upon
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Figure 4. Alternative approaches to decrease sample complexity
(A) Peptide fractionation by the MudPIT, multidimensional chromatography method [11, 21].
After enzymatic proteolysis in solution, acidified peptides are first separated on a strong cation
exchange column (SCX). Then as a discrete fraction of peptides are displaced from this column,
peptides are further resolved by a reverse phase (RP) chromatography column followed by direct
injection into the MS-instrument. (B) Proteins are first separated by ID (example shown) or 2D
SDS-PAGE. The protein of interest is cut out of the gel and subjected to an in-gel digestion to
generate peptides. (C) Schematic presentation of a TAP-tagged protein [22]. (D) Interacting
partners of the target protein (depicted in green and red) are identified from non-specific
contaminating proteins (depicted in grey) after two affinity purification steps. The first step is
based on affinity of protein A to IgG beads. After removal of unbound proteins, the target protein
is released upon TEV cleavage. The second step is based on the affinity of the calmodulin binding
peptide for calmodulin beads in the presence of calcium. This purification step removes traces of
non-specific contaminating proteins as well as TEV protease. The target protein and its interacting
partners are collected from the beads upon EGTA elution and identified by MS.
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cleavage with tev protease. Thus the IgG binding domain remains attached to the beads.
The second purification step is based on affinity of a calmodulin binding peptide (the
second tag) to calmodulin beads in a presence of calcium. Upon removal of any carryover non-specific proteins and tev protease by washing steps, the over-expressed protein
and its interacting partners are eluted from the beads in the presence of chelating agents,
such as EGTA, and then separated by SDS-PAGE (Figure 4D). The protocols described
so far allow for the identification of proteins as cellular components and members of
protein-protein interaction networks. However, if the biological questions are rephrased to
monitor differences in protein abundance or their post-translational modifications under
various conditions, labelling protocols that allow quantification and direct comparison of
two different states in the same analysis are required.

Mass spectrometry as a quantitative tool
Mass spectrometry is not inherently a quantitative technique due to the fact that
different molecular species (e.g. different peptide sequences) will have diverse ionization
efficiencies. Several quantitation methods for MS-based approaches have been devised
and can be divided into two types, absolute and relative [14]. The general principle
behind these methods takes advantage of the fact that chemical and physical properties of
isotopically labelled compounds are identical to their naturally occurring counterparts,
with the exception of their mass [23, 24]. Thus stable isotopic nuclei (carbon-13,
nitrogen-15, oxygen-18 and deuterium) will not alter ionization efficiency and can be
either incorporated into peptides and function as relative references, or included into
samples as internal standards [25].
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The relative labelling can be either accomplished by metabolic incorporation (i.e. stable
isotope labelling by amino acids in cell culture, SILAC [23]), by post-harvest chemical
derivatization method (i.e. isotope-coded affinity tag, ICAT, [24], isobaric tags for
relative and absolute quantification, iTRAQ, [26]), or by incubation with H2180 during
enzymatic digestion [27].
Absolute quantification is based on 'spiking' known quantities of chemically
synthesized stable isotope labelled peptide as internal standards (absolute quantitation,
termed AQUA, [28]). The major limitation of the AQUA method is the requirement for
chemical synthesis of isotope containing peptide equivalents to proteolytic digest of all
generated peptides, and thus is restricted to a small number of pre-selected proteins [14].
With regards to the relative quantification strategies, the least commonly utilized
approach is based on proteolytic labelling with oxygen-18 during proteolytic digestion.
As this can result in a 2 or 4 Da shift, due to incorporation of either one or two oxygen-18
atoms into the carboxyl terminus of each generated peptide, this may complicate the
quantification. Also, if only one oxygen is replaced it might cause an overlap of isotopic
envelopes [14, 29], as each MS-detected signal corresponding to a peptide consists of
isotope cluster of peaks [7]. These peaks are separated by 1 Da, caused by the 1%
probability in nature of each carbon-12 atom to be a carbon-13 isotope [7]. In addition,
further complications exist in that variability is added as a result of slow or incomplete
incorporation of the oxygen-18 for highly acidic peptides [30].

Mass spectrometry and isotopic in vivo labelling
Biologists often ask whether a certain protein is present within a particular
sample, and if the answer is yes, a typical follow-up question is in what amount. In order
13

to address the quantitative part of their questions, so called "metabolic" or "in vivo"
labelling methods were developed, which are based on the incorporation of stable
isotopes containing essential amino acids into each synthesized protein. The original
proof-of-principle SILAC report used incorporation of an isotopically labelled deuterated
form of leucine (2H3-Leu) in sample A ('heavy') which was compared to sample B, in
which cells were grown in a media containing normal leucine (H-Leu, 'light') [23]. After
experimental treatments (in this case myoblast differentiation), the protein populations
were harvested and mixed together, separated on SDS-PAGE and proteolytically digested
(Figure 5A). As the exact ratio between labelled and unlabelled proteins/peptides is not
affected, quantitation (based on peak intensity) can be performed either on the peptide
mass or fragment spectrum as the fragmentation patterns are identical and no
complications are introduced due to label (3 Da difference). The advantages of this
labelling technique include the ability to label many proteins in a cell (as more than half
of tryptic peptides contain leucine), there is no difference in labelling efficiencies
between samples (cells are exposed to isotope containing amino acids for a prolonged
period of time, five days in culture, prior to treatment), and the labelling is consistent
among numerous peptides from the same protein and is sequence specific [23]. However,
problems were encountered upon reverse phase separation of peptides due to both, the
deuterium label and the fact that not all peptides generated by trypsin digest were
labelled. In the second generation of labelled amino acids, the stable isotopes were
carbon-13 and nitrogen-15, and the label was incorporated into lysine and arginine,
instead of leucine. As trypsin (peptide bond cleavage at arginine and lysine residues) is
the most commonly used protease in MS-based experiments, when isotopicaly labelled
lysine (13C615N2-Lys) and arginine (13C6I5N4-Arg) are incorporated, all detected peptides
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Figure 5. Quantitative mass spectrometry
(A) A schematic presentation of the SILAC method, the "metabolic" or "in vivo" labelling
technique [23]. For sample A, cells are grown in the presence of an isotopically labelled 'heavy'
amino acid (either Leu, Lys or Arg, or a combination of Lys and Arg) prior to the experiment.
Thus all proteins are isotopically labelled. For sample B, the cells are grown in normal media and
thus the proteins will contain 'light' labelled amino acids. One culture is exposed to the desired
treatment after which cells are lysed and proteins are extracted from both samples, afterwards
both samples are mixed together and might or might not be subjected to purification protocols
prior to enzymatic cleavage into peptides. The peptides corresponding to the same protein from
two different samples have the same properties, with the exception of the isotopic label (and
subsequently different m/z) thus allowing quantification. This therefore allows the determination
of the affect of the treatment on protein levels. (B) A schematic representation of the ICAT
method, one of the "in vitro" labelling techniques [24]. ICAT allows isotopic labelling of cysteine
residues from numerous samples, including non-living cells and tissues. The first step requires
denaturation of proteins followed by treatment with reducing agent, thus generating free thiol
residues susceptible to ICAT derivatization. Then the samples under comparative study are
combined and subjected to enzymatic proteolysis. The labelled peptides are purified by cation
exchange and avidin affinity columns. After biotin cleavage, quantification of purified cysteine
containing peptides is performed by MS.
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are labelled with an 8 Da mass shift difference for Lys and a 10 Da for Arg containing
peptides [31].
An alternative approach to the TAP-tag system for identification of proteinprotein interactions involves the use of untagged endogenous proteins, at their normal
cellular levels, in a quantitative immunoprecipitation combined with a knockdown screen
[32]. This method, QUICK is a hybrid of SILAC, RNA interference (RNAi) and
coimmunoprecipitation [32]. As RNAi allows specific depletion of a protein, its
interacting partners can be identified upon immunoprecipitation with endogenous
antibody, elution, digestion and MS-based comparison of peptide ratios between 'light'
cells, where the protein under study has been down-regulated and non-treated 'heavy'
cells. After the immunoprecipitation and digestion, MS-analysis detects peptides at a
higher intensity corresponding to the protein under study and its interacting partners in
the 'heavy' labelled sample (non-treated), as these are decreased or absent from RNAi
treated cells; whereas peptides corresponding to contaminating proteins are observed at
similar levels [32].
Another promising adaptation of SILAC is in a screen for identification of novel
DNA-protein interactions [33]. Protein levels are often a reflection of the regulation of
transcription as the case of the presence/absence of specific transcription factors
recognition sites within promoter regions (upstream of transcription start site). DNA
methylation also affects transcript levels. For example, in mammals in approximately
80% of all genes the promoter regions contain stretches of cytosine-guanine (CG)
nucleotides, so called CpG islands [34]. The cytosine within CpG dinucleotides is
susceptible to methylation, an event that potentially may disrupt the ability of a
transcription factor to bind their recognition sequence. CpG island methylation within
16

promoter regions of numerous genes have also been shown to display tissue specific
patterns as well as a correlation with many malignancies [34]. In order to identify
signalling networks mis-regulated due to methylation of a specific CpG island,
biotinylated double stranded synthetic oligonucleotide containing either fully methylated
cytosine residues within a CpG island or a corresponding non-methylated sequence were
separately immobilized onto streptavidin beads [33]. Affinity chromatography was
performed separately for DNA containing the methylated CpG island and 'heavy' (2H4Lys) labelled nuclear extract and for DNA containing the non-methylated CpG island and
'light' labelled (H-Lys) nuclear extract. Afterwards samples are combined and DNAprotein complexes were eluted by restriction enzyme digestion, as the nucleotides were
engineered to contain endonuclease recognition site. Thereafter protein complexes are
either immediately digested with a protease in-solution or proteins can be first separated
on SDS-PAGE and then in-gel digested. Lysine containing tryptic peptides originating
from DNA methylation specific interacting proteins were detected at a higher peak
intensity for the 2H4-form (mass shift difference of 4 Da), while DNA affinity purified
non-specific proteins displayed 1:1 ratio between isotopic forms [33].

Mass spectrometry and non-isotopic quantitation
In the case where samples have not been or cannot be isotopically labelled,
approaches for label-free quantitative proteomic have been developed. These methods
allow for extraction of quantitative data from mass spectra, and require implementation of
computational algorithms. One of the label-free quantitative methods is based on
normalization of the number of observed peptides to the number of observable peptides
for the protein under study, the so-called protein abundance index (PAI) [35, 36]. This
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was later modified to exponentially modified PAI (emPIA) method, as it was observed,
that the number of peptides observed has a logarithmic relationship to the amount of
protein within that sample [37]. Furthermore, this method was recently further enhanced
by the inclusion of correction factors that allow the measurement of absolute protein
concentration per cell from the proportionality between protein abundance and the
number of observed peptides [38]. The second label-free quantitative method is only
applicable in highly reproducible liquid-chromatography interfaced MS-instruments. This
method is based on extracted ion current, which is the area under the curve, when signal
intensity as peptide elutes from chromatographic column, is plotted versus time [39]. The
extracted ion current is linearly related to the amount of particular peptide (extracted ion
currents for different peptides of the same protein are very different) under the same
experimental conditions [14]. Samples under comparative analysis are processed and
analyzed separately, one after another. It is noted that slight changes in sample processing
or the presence of contaminants, such detergents, interfere with quantification [14].
Applications of this label-free quantitative analysis include, but are not limited to, protein
correlation profiling, an adaptation to provide protein abundance profiles upon
fractionation procedures [40] and detection of changes in the cell surface proteome [41].

Mass spectrometry and isotopic in vitro labelling
A second category of isotopic labelling strategies is based on chemically targeting
reactive groups on side chains of amino acids or peptide termini. Some of these labelling
approaches are performed at the peptide level and some at the protein level, depending
upon the experimental questions. As the above-described in vivo labelling techniques are
limited to cells that can be cultured in appropriate media, the alternative approaches for
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incorporation of labels allowing quantitative proteome analysis can be performed on a
wide variety of samples, including patient specimens.

The most popular of the isobaric mass tags, iTRAQ allows concurrent analysis of
up to eight different samples and consists of an amine-specific reactive group, a reporter
mass group (variable mass of 114-117 Da (for 4-plex assays) or 113-121 Da (for 8-plex
assays)) and a balancer group (variable mass of 191-188 Da or 192-184 Da) [26]. The
iTRAQ label introduces a highly basic group at the N-terminus of peptides and lysine side
chains, and during MS/MS the reporter groups are released as singly charged ions of
masses at 114, 115, 116 and 117 m/z (in a 4-plex experiment) thus allowing
quantification based on their ratios.
Recently introduced (by Applied Biosystems) the non-isobaric, amine based
isotope-coded reagent, mTRAQ, allows concurrent quantification of three samples, as
addition of 13C and 15N containing tags as precursors that result in a mass shift of 0, 4 and
8 Da for arginine and 0, 8 and 16 Da for lysine tryptic peptides [29].

Another class of labelling reagents has specificity towards sulfhydryl groups, a
reduced form of the side-chain in cysteine residues. These isotope-coded affinity tags
(ICAT) contain a thiol-specific reactive group (iodoacetamide) and a biotin affinity tag,
separated by an isotopically coded linker [24]. This quantitative labelling technique was
designed in order to simplify the complex peptide pool prior to MS-analysis, while
maintaining high proteome coverage. Cysteine was chosen because it is a rare, but
functionally essential amino acid, with most proteins containing at least one cysteine.
This fact reduces the complexity of the peptide sample by approximately an order of
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magnitude (Figure 5B) [24]. The major caveat of this method is that the representation of
proteins that lack cysteine residue is compromised. Based on current estimates this
represents approximately 5% of human proteins [42]. In the first generation of ICAT
reagents the difference between 'light' and 'heavy' was 8 Da, due to incorporation of
eight deuterium atoms into the 'heavy' tag [24]. There were a few shortcomings related to
the design of these labelling tags, such as a shift in the elution of corresponding peptides
from reverse phase chromatography due to deuterium modification and ambiguities in
assigning peptides with more than one cysteine. Note, a difference of 16 Da may
represent the presence of either two labelled cysteine residues or oxidation of methionine.
An additional difficulty was the possibility of undesired fragmentation at the biotin tag,
instead of fragmentation at the peptide backbone during MS/MS. This led to development
of a second generation of ICAT reagents [43], which are now commercially available.
These ICAT reagents include an acid-cleavable linker group between the biotin moiety
and sulfhydryl reactive isotope tag, while the 'heavy' reagent contains nine 13C atoms
instead of eight deuterium atoms [43, 44]. These reagents allow the comparison of the
content and relative abundance between two samples, by first reducing the side chains of
cysteinyl residues in a sample representing one cell state followed by derivatization with
Tight' ICAT reagent. In the second sample, equivalent groups are first reduced and then
derivatized with 'heavy' ICAT reagent [24]. After labelling, the two samples were
combined and proteolytically digested; thereafter the resulting peptides were separated by
multidimensional chromatography, including isolation of tagged peptides by avidinaffinity. Quantification is based on comparison of the relative signal intensities (ratios)
between peptide ions pairs of identical sequence, with a mass difference due to
incorporation of 'light' and 'heavy' ICAT tags which are chemically identical, thus
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allowing an accurate measure of the relative abundance of the peptide (hence the protein)
[24]. The application of ICAT-labelling to study changes in protein abundance at the
entire proteome level ranges from analysis of differences in microsomal fractions
between naive and differentiated human myeloid leukemia cells [45], in tracheal tissue of
cystic fibrosis patients [43], and serum of hepatocellular carcinoma patients [46], just to
mention a few from a long list.
The thiol group of cysteine residue is very susceptible to oxidation by reactive
oxygen species or reactive nitrogen species [47]. Furthermore, thiol groups (-SH) are
essential for the function of many proteins, in that oxidation (in a form of disulfide, -S-S)
may increase or decrease a protein's activity, thus affecting their function. ICAT reagents
have provided an invaluable tool to identify which cysteines are susceptible to oxidation
(for example after exposure to hydrogen peroxide) and for the quantification of the
amount of oxidized cysteine residues [48, 49]. This procedure is based on the premise that
oxidized cysteine residues are not susceptible to ICAT derivatization, when samples are
labelled under non-reducing conditions. Thus normal sample would be labelled with
Tight' ICAT reagent, and the experimental sample exposed to oxidant stress, would be
labelled with 'heavy' ICAT reagent, thus the decrease in specific labelling of oxidantsensitive cysteine thiols can be quantified from the ratio of ICAT reagents.
One of key redox modulators that contain a CysXXCys motif within two active
sites is protein disulfide isomerase (PDI). In collaboration with Dr. B. Mutus, Department
of Chemistry and Biochemistry, University of Windsor, ICAT labelling was utilized to
identify and quantitate redox sensitive cysteines on PDI after auto-oxidation. This study is
presented in detail in Chapter 3.
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In addition to identification of redox-sensitive thiols, the ICAT in combination
with labelling has been adapted to trap differential thiols, in a method called OxICAT
[50]. The OxICAT method is based on sequential labelling of the same sample; first free
thiols are labelled with Tight' ICAT reagent after protein(s) denaturation and afterwards
disulfides are disrupted by strong reducing agent, thus allowing for these thiols to be
labelled with 'heavy' ICAT reagent. Cysteines that were originally present as thiols, will
be detected only as Tight' ICAT labelled; whereas cysteines which were originally
oxidized, will be identified by the 'heavy' ICAT modification. This will result in a 9 Da
shift if the peptide contains one cysteine and if more cysteines, multiples thereof. If
cysteines are at redox equilibrium, then both forms (Tight' and 'heavy' ICAT labelled)
for the same peptide would be detected. This approach also provides a novel method to
monitor the kinetics of thiol oxidation by trapping oxidation intermediates within a
purified protein (for example upon oxidative stress, thus activating or inactivating the
protein) [50].
Thiols can also be modified by either S-nitrosylation or S-glutathiolation [51]. The
MS-based approach to identify Cys-SNO modifications, SNO-Site Identification method
SNOSID, is essentially an adaptation of biotin-switch assay [52, 53]. First, all free thiols
in the protein mixture are methylated, then Cys-SNO are selectively reduced (by
ascorbate), thus generating a new unmodified thiols, at which position biotin will be
attached through a disulfide bond (upon addition of N-[6-(biotinamido)hexyl]-3'-(2'pyridyldithio)propionamide, biotin-HPDP). At this time, proteins are proteolytically
digested, biotin-tagged peptides are isolated by avidin-affinity, and subsequently released
by the reduction of the disulfide linker. As this last described method is not based on
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ICAT technology, it serves as an example that alternative methods are available to study
cysteine modifications.

Mass spectrometry andpost-translational modifications
So far, MS-based approaches designed to identify novel proteins and quantitative
differences among samples have been described. Nevertheless, biological functions of
most proteins are regulated through post-translational modifications. The ability to
unambiguously identify these post-secondary modifications (and their location), further
highlights the power of MS. Identification is achieved from MS/MS spectra analysis, as
the observed fragmentation pattern is altered due to the mass shift introduced by the
modification. The acquired spectra can be compared to a predicted fragmentation pattern
(generated by open-source software) including defined modifications introduced at a
specific amino acid. For example, acetylation on lysine residue introduces a mass shift
difference of +42 Da of the parent ion [MH]+ compared to unmodified peptide in MS
spectra (prior to fragmentation), while the position of modified lysine can be assigned by
+42 Da shift detected in MS/MS spectra at the position of this residue. In the case of
methylation, the extent of mass shifts introduces depends on the number of methyl groups
present, i.e. +14 Da for methylation, +28 Da for dimethylation and +42 Da for
trimethylation. Ubiquitination plays an important role in protein stability, as ubiquitinated
proteins are targeted for degradation [54]. The MS-identification of lysine residues
originally modified by ubiquitination is based on detection of ubiquitin remnants, in a
form of a covalently attached glycine-glycine dipeptide, the signature peptide (mass shift
difference at the lysine residue of 114.1 Da), after trypsin proteolysis; sustained by
trypsin missed cleavage at this lysine residue (proteolysis does not occur at modified
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lysines) [55]. Protein modifications by carbohydrates (O-linked and N-linked
glycosylation) have been increasingly recognized as biochemical alterations associated
with malignant transformations and tumorigenesis [56]. Due to the incredible variability
in the glycan structures, and complexity of these modifications, methodologies applied to
their identification and characterization are beyond the scope of this overview.

Mass spectrometry and identification ofphosphorylation sites
Last, but not least, phosphorylation is one of the most important regulatory
modifications, affecting

a broad range of biological functions and processes.

Phosphorylation occurs most commonly on serine residues (86.4%), followed by
threonine residues (11.8%) and rarely on tyrosine residues (1.8%) (values are based on in
vivo phosphoproteome analysis) [57]. Other amino acids that can be phosphorylated are
histidine and glutamic acid [42]. Phosphorylation is detected as a modification of the
peptide by a +80 Da shift in the MS spectra in comparison to the non-phosphorylated
peptide and typical dominant -98 Da and -80 Da fragments detected in the MS/MS
spectra due to neutral losses (the mass of H3PO4, and HPO3 respectively, derived from
phosphoserine and phoshothreonine). In the case of phosphotyrosine, a specific
immonium ion (an internal fragment containing just a single side chain of an amino acid)
is detected at 216.02 m/z [58].
Due to the dynamic nature of phosphorylation, phosphorylated proteins are often
present at low levels, thus the fraction of phosphorylated peptides will be at a much lower
concentration compared to their non-phosphorylated counter-parts (high abundance
peptides cause ion suppression during ionization process) [59]. In addition to low
stoichiometry, phosphopeptides also suffer from low ionization efficiency [59]. These
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problems

can be

circumvented

by techniques that promote

enrichment

of

phosphopeptides.
Originally, three methods were described for the identification of phosphopeptides
from a complex protein mixture. The first one included replacement of phosphate groups
by ethanedithiol, followed by the addition of a biotin tag, the latter allowing
phosphopeptide affinity purification [60]. A limitation of this method includes
complications that arise during the derivatization process and the inability to detect
phosphotyrosine residues, as only phosphoserine and phosphothreonine undergo (3elimination [61]. The second method was based on a chemistry intensive six-step
derivatization/purification

protocol for tryptic peptides, where the capture of

phosphopeptides was accomplished through a reversible covalent linkage to a solid
support [62]. The third method employs phosphopeptide enrichment from whole cell
lysates by immobilized metal affinity chromatography (IMAC) on peptides derivatized by
esterification of carboxylate groups [63]. IMAC has become one of the most commonly
used strategies for phosphopeptide enrichment [5] and will be described in further details
later.
In addition to IMAC, numerous techniques have recently been developed to enrich
for phosphopeptides. For example, strong cation exchange chromatography (SCX-based
strategy), which separates peptides according to ionic charge, allows enrichment of
tryptic phosphopeptides from unmodified peptides (singly charged species elute before
multiply charges ones) [64]. At low pH (2.7) only lysine, arginine, histidine and the
amino terminus are charged with a net charge state of+2 on non-phosphorylated peptide,
while phosphate groups maintain a negative charge with a net charge state of+1 on a
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phosphopeptide [64]. The major caveats of this enrichment technique include the fact that
it is limited to studying trypsin generated proteolytic fragments as well as having an
inability to detect phosphopeptides containing a single histidine residue [65]. The
presence of histidine within a phosphopeptide alters the net charge to +2, the same as
non-phosphopeptides, thus effecting the elution properties of this phosphopeptide from
the SCX-column and hindering detection [65]. Nevertheless, this phospho-enrichment
protocol is powerful and has allowed the phosphoproteomic analysis of the developing
mouse brain [65]. Furthermore, in combination with other phosphopeptide enrichment
methods, SCX-based strategies have been implemented as the first fractionation step in
numerous studies, including the effect of epidermal growth factor induced simulation in
HeLa cells [57], profiling of mitotic phosphorylation [66] and analyses of the
phosphoproteome in mouse liver [67], and Drosophila melanogaster embryos [68].
A motif-specific phosphopeptide enrichment method has also been described that
is useful for characterizing specific kinase targets. The method is based on the
precipitation of phosphopeptides with Ba2+ in the presence of acetone under varying pH
[69]. For example, Ba2+-based precipitation in combination with pH dependent
fractionation and MudPIT separation of peptides was used to analyze nuclear extracts
from HeLa cells. When the identified phosphopeptides were analyzed in a pH dependent
manner, at pH 3.5, 86% of the phosphopeptides were unique and the sequence adjacent to
the phosphorylated residue contained acidic amino acids; at pH 4.6 70% and at pH 8.0
56% of the phosphopeptides were unique. Ba2+-based precipitation at pH 4.6 and 8.0
displayed an increased preference for proline residues C-terminal to the phosphorylation
site. Overall, the pattern of Ba2+ precipitation of phosphopeptides at each pH coincided
with consensus sequences for specific kinases [69].
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As phosphorylation at tyrosine residue ranges between 0.05%> (as determined by
phosphoamino acid analysis [70]) to 1.8% (as determined by phosphoproteome analysis
[57]) of the total cellular phosphorylation, selective enrichment for phosphotyrosines
containing phosphopeptides is necessary when the quest is to identify tyrosine
phosphorylation sites. The method of choice to selectively enrich for these
phosphopeptides is based on peptide affinity purification with an anti-phosphotyrosine
antibody. The immuno-affinity phosphopeptide strategy was first applied to profile
analysis of oncogenic Src (tyrosine kinase) down-stream targets and comparative analysis
of two cancer cell lines derived from anaplastic large cell lymphomas [71]. The same
experimental approach was utilized to study the phosphotyrosine proteome in mouse
brain [72].
In addition to IMAC, a metal oxide affinity chromatography (MOAC) based
method, which utilizes Zr02 and Ti02, has been shown to selectively bind
phosphopeptides [73-75]. The limitation of this enrichment method is similar to IMAC
(discussed below), i.e. the possibility of retention of acidic non-phosphopeptides [74, 75].
When a phosphopeptide standard mixture was isotopically labelled with iTRAQ (to allow
direct comparison) and phosphopeptides were enriched by either Ti02 or Fe3+-based
affinity and then mixed together prior to MS-analysis, comparable performance between
these two technique was observed [58]. Furthermore, when phosphopeptides from
biological sample were SILAC labelled (to quantitate changes in phosphorylation after
EGF stimulation), phosphotyrosine containing proteins were immuno-precipitated with an
anti-phosphotyrosine antibody, protein complexes were separated on a gel and after in-gel
digestion, peptides were enriched by either Ti02 or Fe3, results were similar [58].
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Immobilized metal ions, such as Fe

and Al

bind phosphoproteins and

phosphopeptides with high specificity [76, 77]. Furthermore, after enrichment of
phosphopeptides on either Fe3+ and Ga3+ loaded agarose, phosphorylated residues can be
identified by MS [78]. This experimental protocol is the basis of commercially available
PHOS-Select resin (from Sigma-Aldrich). The major limitations of this enrichment
technique include binding of non-specific peptides and variability in the retention of
phosphopeptides [63, 79]. IMAC enrichment of phosphopeptides has been employed to
identify human mitotic spindle phosphoproteins [80], in the phosphoproteome analysis of
a-factor

arrested

Saccharomyces

cerevisiae

[81]

and

phosphoproteins

in

Schizosaccharomyces pombe [82].

Mass spectrometry and dual specificity phosphatases
Dual specificity phosphatases (DUSPs) are able to remove a phosphate group
from phosphoserine, phosphothreonine and phosphotyrosine residues [83, 84]. This very
heterogenous sub-group is a subfamily of the protein tyrosine phosphatase (PTP)
superfamily [83]. All PTP family members (including DUSPs) contain the invariant
catalytic sequence C(X)sR and the hydrolysis of phosphorylated substrate involves
formation of a stable phosphoryl-intermediate [85, 86]. The DUSPs are the most diverse
group in terms of substrate specificity, and include the following families; MKPs
(mitogen-activated protein kinase phosphatases), Slingshots, PRLs (phosphatase of
regenerating liver), Cdcl4s, PTENs (phosphatase and tensin homologue deleted on
chromosome 10), MTMRs (myotubularins) and the atypical DUSPs [83, 84].
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The atypical DUSPs, a group of 16 members, are generally small, under 250
amino acids, and lack specific mitogen activated protein kinase (MAPK) targeting motifs
even through a few family members can dephosphorylate at least one of the MAPKs
(either Erk, Jnk or p38). These includes DUSP3 (VHR) [87], DUSP14 [88], DUSP18
[89], DUSP19 [90], DUSP22 [91], DUSP23 [92] and DUSP26 [93]. Other members
display a broad range of substrate specificities. For example, laforin dephosphorylates
complex carbohydrates [94] and DUSP11 interacts with RNA [95]. If all of this
heterogeneity and variability within this sub-class of DUSPs is taken into consideration,
we can expect that hYVHl (also known as DUSP 12), the DUSP of interest in the
Vacratsis lab and the only atypical DUSP that contains a zinc-binding domain, to have a
unique role.
YVH1 orthologues are extremely conserved throughout evolution; present in
species as diverse as Plasmodium falciparum [96] to humans signifying YVH1
orthologues as regulators of conserved cellular functions. Interestingly, YVH1
orthologues are present as single gene copies even in advanced mammals such as humans,
suggesting that there has been evolutionary pressure against yvhl gene duplication or
deletion.
Recent projects from our laboratory have used several MS-based approaches to
discover novel hYVHl functions. A MS-based approach was utilized to identify the
cytoprotective heat shock protein 70 (Hsp70) as the first known hYVHl interacting
protein [97]. Phosphatase assays showed that hYVHl is a heat stable enzyme whose
activity during oxidative conditions can be modestly increased in the presence of Hsp70.
Furthermore, this result led to the discovery that hYVHl is a novel cell survival
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phosphatase and can prevent both thermal and oxidative stress induced cell death. This
cytoprotective property requires catalytic competence and the zinc binding domain [97].
Our laboratory also used differential thiol labelling and MS to reveal that the
cysteines in the zinc binding domain serve a redox buffer role, allowing hYVHl to
function under oxidative conditions known to inactivate cysteine based phosphatases
[98]. In the present study, outlined in Chapter 4, a MS-based approach was also utilized to
identify phosphorylation sites within hYVHl. Not only are these the first phosphorylation
sites reported for any YVH1 orthologues, but this result led us to discover that hYVHl
expression affects cell cycle progression.
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Objectives of this Thesis
Recent developments in the mass spectrometry field have facilitated the
applicability of this experimental tool to study a variety of biological questions. These
include, but are not limited to, identification of proteins or post-translational
modifications, and quantitative analysis of proteins after modification of peptides with
isotopically labelled tags. This dissertation is comprised of three research chapters that
examine various applications of MS-based methods to study biological questions.

Chapter 2 investigates the identity of a 21 kDa protein from encysted embryos of
brine shrimp Artemia franciscana as a group 1 Late embryogenesis abundant protein by a
MS-based de novo sequencing approach.

Chapter 3 examines the redox status of cysteine residues within recombinant
human protein disulfide isomerase after auto-oxidation conditions employing the isotopecoded affinity tag (ICAT) technology and mass spectrometry.

Chapter 4 identifies three in vivo phosphorylation sites on hYVHl using a
combination of a phosphopeptide enrichment protocol and mass spectrometry. This study
also examines the effect of overexpressing hYVHl and phosphospecific mutants on
hYVHl localization and progression through the cell cycle. In addition, phenotypes
observed due to down-regulation of hYVHl with siRNA are also described.
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CHAPTER 2

Identification of group 1 LEA protein from A. franciscana by de novo MS

This chapter incorporates the outcome of joint research undertaken in collaboration with
Michelle A. Sharon under the supervision of Dr. Alden H. Warner, Department of
Biological Sciences. The collaboration is covered in Chapter 2 of the thesis. In all cases,
the key ideas, primary contributions, experimental designs, data analysis and
interpretation, were performed by the authors; Michelle purified a 21 kDa protein from
Artemia franciscana, PCR amplified cDNA from an embryonic library corresponding to
its gene and performed the initial characterization of this protein. My contribution to this
manuscript was the de novo identification of this protein using mass spectrometry (MS).
Since the genome of this organism has not yet been sequenced, this included in silico
analysis for the identification. Based on the peptide sequence corresponding to a
conserved motif, the 21 kDa protein was identified as a member of group 1 Late
embryogenesis abundant (LEA) family. Once Michelle completed the gene amplification,
I was able to match the peptide sequences generated by MS and thus further confirm the
identity of the 21 kDa protein.

The results were published: Sharon, M.A., Kozarova, A., Clegg, J.S., Vacratsis, P.O., and
Warner, A.H. (2009). Characterization of a group 1 late embryogenesis abundant protein
in encysted embryos of the brine shrimp Artemia franciscana. Biochem Cell Biol 87,
415-430
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Introduction
The brine shrimp, Artemia franciscana is a primitive crustacean, able to survive
under very harsh hypersaline conditions with their embryos among the most resistant
multicellular eukaryotes to environmental stress [1]. Encysted embryos can survive
severe desiccation, anoxia, extremes in temperature, and various forms of radiation [1].
Under conditions of stress Artemia embryos, which are encysted, undergo a reversible
state of dormancy termed diapause that involves both, developmental and metabolic
arrest. Previously identified proteins restricted to diapause include p26, a member of the
small heat shock-a-crystallin family [2, 3] and artemin, a heat-stable RNA binding
protein [4]. However, neither of these proteins has been directly implicated in the ability
of these embryos to undergo virtually complete water-loss, thus implying the involvement
of another protein(s) in addition to the known function of carbohydrates.
Late embryogenesis abundant proteins (LEA), a group of hydrophilic proteins,
have been proposed to protect cellular and molecular structures from low temperature and
desiccation-induced damage [5, 6]. Originally identified only in plants, expression of
these proteins is pre-programmed during the later stages of seed development. However,
they can also be induced by environmental stress, including desiccation, cold and osmotic
shock [7]. LEA proteins have been categorized into 6 groups based on their primary
amino acid sequence and expression patterns. Group 1-3 LEA proteins are characterized
by the presence of specific sequence motifs. The group 1 LEA proteins contain a 20
hydrophilic amino acid motif. The group 2 LEA proteins exhibit at least two of three
distinct sequence motifs (termed the Y-, S- and K-segments). The group 3 LEA family
members contain multiple copies of an 11 amino acid motif [7]. Categorization within
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group 4-7 LEA proteins (with exception of Group 5, that contains hydrophobic or atypical
LEA proteins) remains under discussion [7], despite the fact that several distinctive
highly conserved motifs have been described [8].
In addition to plants, LEA proteins have also been described in animal species
including the nematode Caenorhabditis elegans [9]. C. elegans is able to enter into a
reversible state of dormancy during development, the so called dauer juvenile larval
stage, when the food supply is limited. While in the dauer form, these worms exhibit
increased tolerance to desiccation and express group 3 LEA-like proteins (Ce-lea-T),
while the adults are desiccation sensitive [9].
The most complex metazoan for which group 3 LEA proteins have been described
thus far is A. franciscana [8]. AfrLEA 1 and AfrLEA 2 were identified by a differential
developmental stage specific cDNA library screen [10].
In addition, a proteomic study identified LEA proteins in multiple spots on 2D-gels
belonging to two families; one with a sequence homology to group 3 LEA protein in C.
elegans and the others with similarities to AtEml in plants [11].
As A. franciscana is a model organism for the study of adaptation mechanisms to
extreme environmental conditions, in a quest to identify proteins that enable the
dehydration tolerance of the encysted embryos, an analysis of heat-stable proteins was
performed. Interestingly, a unique protein with an apparent mass of 21 kDa (p21) was
prominent among the heat-stable proteins. Since to date Artemia's genome has not been
sequenced, we utilized de novo mass spectrometry to identify a peptide fragment
corresponding to p21. Furthermore, using MALDI-TOF we generated an amino acid
sequence for the peptide that enabled the design of DNA oligonucleotides, which in turn
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allowed the amplification of this gene from an Artemia embryonic cDNA library. This is
the first report describing identification of a group 1 LEA protein from an animal species.

Materials and Methods

Dr. A. H. Warner and members of his research group provided an SDS-PAGE gel
containing heat-stable protein p21 purified from A. franciscana encysted embryos. Details
related to the purification protocol, MS-identification (described in detail below), PCR
based amplification and DNA sequencing; as well as characterization of group 1 LEA
protein (p21) were published by Sharon et al. [12].

De novo protein sequencing by MALDI-PSD
Following electrophoretic separation by SDS-PAGE and visualization by
coomassie blue, the band corresponding to p21 was excised. Prior to in-gel proteolytic
digestion, the gel piece was destained (50%> acetonitrile, 50%> 50 mM ammonium
bicarbonate) for 1 hr at 37° C, dehydrated in 100%) acetonitrile and excess liquid was
removed in a speed vac. Thereafter, the gel piece was rehydrated in digestion buffer (50
mM ammonium bicarbonate) and digested with 200 ng of trypsin (Promega) for 12 hr at
37° C. Peptides were extracted (60% acetonitrile, 0.1%) trifluoroacetic acid) and desalted
using micro-Ci8 Zip Tips (Millipore). A portion of extracted peptides was subjected to
chemically assisted fragmentation (CAF) modification in order to enhance the production
of y-ions using the CAF Sequencing Kit according to manufacturer's instructions
(Amersham Bio sciences). Modified peptides were mixed at a ratio of 1:1 with matrix
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solution (10 mg/mL a-cyano-4-hydroxycinnamic acid in 60%> acetonitrile, 0.1%>
trifluoroacetic acid) on the target plate. Peptide mass fingerprints were obtained by
matrix-assisted laser desorption-ionization-time of flight (MALDI TOF) in a reflector
mode on a MALDI-TOF DE-Pro instrument (Applied Biosystems) using an accelerating
voltage of 20,000V. MS spectra were internally calibrated using trypsin autolysis peptide
masses. MS spectra were processed by use of the Data Explorer software (Version 4.0,
Applied Biosystems) with a S/N threshold of 30 to detect peaks. Selected parent ions
were subjected to post-source decay analysis using 11 segments stitched together by the
Data Explorer software (Version 4.0, Applied Biosystems). Post-source decay spectra
were calibrated with angiotensin I ([MH]+ 1296.69) fragment ion masses. Owing to the
lack of genomic sequences available for A. franciscana, de novo sequencing
interpretation of the CAF-post source decay spectra was performed manually. A fragment
mass tolerance of 0.3 Da was used to assign amino acid sequences. Peptide sequences
were then searched against the NCBI non-redundant database using the NCBI BLAST
program (version 2.2.14, www.ncbi.nlm.nih.gov/BLAST).

De novo protein sequencing by MALDI-MS/MS
In order to increase sequence coverage, an "in-gel" digestion of p21 was
performed with either trypsin (Promega) (as described above) or 1 jag of endoproteinase
GluC (Roche) for 12 hr at 25° C. Upon extraction, peptides were analysed on a 4800
MALDI TOF/TOF Analyzer (Applied Biosystems) operated in the positive ion reflectron
mode. The MS data were internally calibrated using autolysis peaks of trypsin or GluC.
Precursor ions with an S/N ratio of 30 were selected for tandem MS (MS/MS). All
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MS/MS spectra were calibrated using MS/MS fragment masses from angiotensin I
([MH]+ 1296.69). MS and MS/MS data were processed using the Data Explorer software
(Version 4.5, Applied Biosystems). De novo sequencing was performed manually using a
mass error of 0.2 Da between fragment ion masses to assign amino acid sequences. Once
the DNA sequencing experiments were complete, the deduced protein sequence (entered
into NCBI database under accession number EF656614) was used to corroborate MS
data.

Results

Enrichment of a unique 21 kDa heat-stable cytoplasmic protein from A.
franciscana dormant encysted embryos was initially observed after separation on SDSPAGE. In order to identify this protein and obtain sequence information for cloning
purposes, a MS-based approach was employed. The peptide fingerprint generated from
trypsin digest, as well as the PSD-spectra acquired for a few peptides did not yield any
useful matches when analysed against the publicly available databases (including NCBI
ESTs). As a result of this and since the complete genome sequence of A. franciscana is
not available, de novo sequencing was necessary in order to assign identity to the 21 kDa
protein. Derivatization of the tryptic peptides by the CAF reagent (chemically assisted
fragmentation) greatly simplified the interpretation of MS/MS spectra, as only y-ion
series were detected, thus enabling amino acid assignment [13, 14]. The amino acid
sequence of the CAF-modified peptide at [MH+] 1711 m/z was deduced as the following
sequence: AE(K/Q)(I/L)GHEGYVEMGR (Figure 1A). A search of the NCBI database
using the BLAST algorithm indicated that this 14 amino acid peptide showed significant
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Figure 1. Analysis of the 21 kDa protein by matrix-assisted laser desorptionionization (MALDI)-tandem mass spectrometry and de novo sequencing
(A) MALDI-post-source decay spectrum of chemically assisted fragmentation-modified
tryptic peptide at m/z 1711.9. The y ion fragment ion series in annotated along with the
loss of sulfonate group. (B) Tandem mass spectrometry spectrum of a tryptic peptide at
m/z 1584.0 generated by a MALDI TOF/TOF instrument. The detected y and b ion
fragment masses are annotated. For the deduced sequences, small font indicated the
inability to differentiate between glutamine and lysine, or isoleucine and leucine.
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similarity to the LEA family of proteins. Furthermore, this sequence was 71% identical to
the group 1 LEA protein consensus sequence, thus far only described in few non-plant
species [7, 8]. It is worth mentioning that the group 1 LEA protein sequence motif
GGQTRREQLGEEGYSQMGRK is commonly present in several copies, ranging from
up to four in plants and up to eight in other organisms [8]. The sequence of the CAFmodified peptide was used to design the original set of PCR primers for amplification of
this gene from an embryonic cDNA library. The presence of repetitive sequence provided
challenges during cloning efforts, as well as complicated assignments of unmodified
MS/MS spectra. Fortunately, we detected a peptide ([MH+] 1584.0 m/z) which was not a
part of the repeating motif and were thus able to manually assign the amino acid sequence
to (K/Q)(K/Q)MSRADYAAMG(K/Q)K (Figure IB). It is noteworthy to mention, that
this peptide was only detected in the unmodified trypsin digested sample, therefore the
acquired spectra contained both, b- and y-ion fragment series, thereby further increasing
the complexity of this assignment. The amino acid sequence of this peptide was used to
design oligonucleotide primers to obtain the entire gene encoding the 21 kDa protein,
including the C-terminal end.
Upon successful completion of the PCR-based amplification of the DNA sequence
for group 1 LEA protein, the deduced sequence was used to obtain higher sequence
coverage from the generated tryptic peptides (Figure 2). Overall, six peptides were
subjected to MS/MS analysis, while four ([MH+] 1546.8 m/z, 1668.8 m/z, 1675.8 m/z and
1704.8 m/z) of them corresponded to the originally identified CAF-modified peptide with
variability in one to two amino acids. Therefore, these peptides represent the
characteristic repeats found in group 1 LEA proteins. The fifth peptide ([MH+] 1860.9
m/z) was an arginine miscleavage of one of the four peptides ([MH+] 1704.8 m/z) and the
47

A
100-j
M-

,1860.9189 P

30-

,,1376.9152

70
60

1675.3212'

^

50
40

1684804S
' ox
1704.8101*
1720.3044

f

,1562.7687

30
,1 743.8036*

20
^1575.7657*

1 j

10
^L.

1500

A-

uJ,J
1600

1700

U
1800

-*u- • *
1900

2000

Mass (m/z)

B
m/z
1546.7748
1668.7971
1675.8212
1704.8101
1743.8036
1860.9189

;i
'

error [Da]
(+0.0066)
(+0.0437)
(+0.0468}
(+0.0456)
(-1.0069)
(+0.0526)

peptide
AEK/Q'/LG HE G YVK/QM GK
AEK/Q'/LGTE G YK/QE M GK/QK
AEK/Q'/LGHEGYVEMGK/aK
AEK/Q'/LG HE G Y,4VQE M GK/QK
1
V/ Q K / Q mSRADYAAm GK/QK
RAEK/Q'/LG HEG YK/QE M GK/QK

c
1
41
81
121
151

AEQUGHEGYQ EMG'QK?
AEQLGHEGYVEMGQK
ftEQLGTEGYQ bMGQKU
KQQMSRADYAAMGQK

AEQLGHEGYVEMGR :
ftEQLGTEGVQ EMGQKl"
ftEQUGHEGYQE^GQrC
AEQLGHEGYVKMGK. .

Figure 2. Analysis of trysin generated peptides from the 21 kDa protein by matrix-assisted
laser desorption-ionization (MALDI)-tandem mass spectrometry
(A) MALDI-TOF/TOF spectrum of the 21 kDa protein digested with trypsin. Peaks indicated
with asterisks were subjected to MS/MS analysis. Peaks indicated with ox, represent methionine
oxidation products. The peak at 1860, denoted with a P, represents a peptide containing
polymorphic mutation. (B) Tabular presentation of peaks assigned for group 1 LEA protein
sequence as determined by DNA sequencing from PCR-based cDNA library screen (for
corresponding MS/MS spectra, see Figures 2D-2H) (EF6566124). (C) Protein sequence of group
1 LEA protein where the detected and sequenced peptides from the tryptic digest are underlined,
while in boxes are identical peptide sequences found to be presented at multiple positions. Amino
acids in grey colour correspond to the part of the protein from which peptides have not been
detected or sequenced. Overall sequence coverage from the tryptic digest is 64.8%.
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Figure 2. continued
MS/MS annotated spectra of tryptic peptides at 1546.0 m/z (D) and 1668.0 m/z (E).
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Figure 2. continued
MS/MS annotated spectra of tryptic peptides at 1675.0 m/z (F) and 1704.0 m/z (G).
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MS/MS annotated spectra of tryptic peptide at 1744.0 m/z (H).
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sixth peptide ([MH+] 1743.8 m/z) was a lysine miscleavage and oxidized methionine
version of the previously described unique sequence ([MH+] 1584.0 m/z). Not
surprisingly, sequences of two peptides identified by MS/MS ([MH+] 1668.8 m/z and
1704.8 m/z) were present within the group 1 LEA protein in duplicates. The sequence
coverage from tryptic digest is 64.8%.
In order to obtain more sequence information pertinent to group 1 LEA protein,
Glu C generated peptide fragments were analyzed in similar fashion (Figure 3). Overall,
seven peptides were subjected to MS/MS analysis, five were unique fragments
representing the group 1 LEA repeats ([MH+] 945.5 m/z, 1100.6 m/z, 1205.7 m/z, 1664.9
m/z and 2173.1 m/z), while one peptide ([MH+] 1753.9 m/z) was the result of a GluC
miscleavage ([MH+] 1205.7 m/z). Similar to trypsin generated peptides, one GluC peptide
([MH+] 1178.6 m/z) was assigned to the group 1 LEA protein three times. The sequence
coverage from GluC digest is 51.1%. Combined sequence coverage from both proteolytic
digests is 92.3%. Overall, a novel protein from A. franciscana encysted embryos (p21)
was identified as a group 1 LEA protein by de novo sequencing. DNA sequence
corresponding to this protein was corroborated by MS/MS data with high sequence
coverage.

Discussion

As the studies on A. franciscana continue to shed light onto the molecular
mechanism underlying tolerance to extreme environmental stress conditions, more protein
families will be identified that facilitate survival of these embryos under virtually
complete loss of cellular water for prolonged periods of time. Expression of LEA proteins
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Figure 3. Analysis of GluC generated peptides from the 21 kDa protein by matrix-assisted
laser desorption-ionization (MALDI)-tandem mass spectrometry
(A) MALDI-TOF/TOF spectrum of the 21 kDa protein digested with GluC. Peaks indicated with
asterisks were subjected to MS/MS analysis. Peaks indicated with ox, represent methionine
oxidation products. (B) Tabular presentation of peaks assigned for group 1 LEA protein sequence
as determined by DNA sequencing from PCR-based cDNA library screen (for corresponding
MS/MS spectra, see Figures 3D-3J) (EF6566124). (C) Protein sequence of group 1 LEA protein
where the detected and sequenced peptides from the GluC digest are underlined, while in boxes
are identical peptide sequences found to be presented at multiple positions. Amino acids in grey
colour correspond to the part of the protein from which peptides have not been detected or
sequenced. Overall sequence coverage from GluC digest is 51.1%.
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MS/MS annotated spectra of GluC peptides at 945.0 m/z (D) and 1100.0 m/z (E).
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MS/MS annotated spectra of GluC peptides at 1178.0 m/z (F) and 1205.0 m/z (G).
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Figure 3. continued
MS/MS annotated spectra of GluC peptides at 1664.0 m/z (H) and 1754.0 m/z (I).
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MS/MS annotated spectra of GluC peptide at 2173.0 m/z (J).
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often correlates with improved stress tolerance [7]. A heat-stable cytoplasmic p21 protein
was identified as a group 1 LEA protein. Following identification, further analysis of this
protein demonstrated a potential role for group 1 LEA proteins in desiccation tolerance of
encysted embryos due to its ability to prevent drying-induced protein aggregation [12].
LEA family members are predicted to be generally small intrinsically
unstructured proteins [7, 8]. The A. franciscana group 1 LEA protein is composed of 182
amino acids, from these 23% are glycine residues, which is in accordance with the group
1 LEA protein characteristic high content of glycine residues (approximately 18%) [8]. In
addition, the sequence analysis revealed a large proportion of charged residues,
contributing to the high hydrophilic nature of this protein. Furthermore, the sequence of
the A. franciscana homologue lacks cysteines, a general characteristics of group 1 LEA
proteins. Further supporting evidence that the identified protein is a group 1 LEA member
is based on the regular spacing of glycine and glutamic acid residues within a period of
twenty amino acids [7]. Sequence analysis of A. franciscana group 1 LEA protein is in
agreement with this requirement.
The A. franciscana group 1 LEA protein contains eight tandem repeats of the 20
amino acid motif characteristic for group 1 LEA proteins. Overall, the repeats are very
similar to each other. The first six repeats are 80% identical. The first and second and
fourth and fifth repeat sequences are 90% identical, while 95% identity is observed
between second and third and fifth and sixth repeat sequences. The tandem repeats
become more degenerate towards the carboxy terminus. Repeats six and seven are 75%
identical, while repeat seven and eight are only 35% identical. Similarly, a group 3 LEA
protein, AfrLEAl, from A. franciscana displays divergence in nine characteristic repeats
towards the carboxy terminus [10].
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The presence of the tandem motifs described above greatly increased the
complexity of the MS-spectra annotation. Many ionized peptides corresponded to the
motif sequences with alterations in one or two amino acids, this caused by the variability
among the repeats. Additionally, as the original heat stable protein sample was obtained
from a population of encysted A. franciscana embryos, few polymorphisms were detected
at the DNA levels as well as by the MS-peptide analysis. Most of the de novo MS/MS
spectra were annotated manually, however once the PCR-based amplification of this gene
from embryonic cDNA library was completed, the translated DNA sequence allowed for
comparison between observed peptides and their corresponding amino acids with in silico
generated fragments. In silico digest of the group 1 LEA protein was performed with MSDigest software from Prospector (available at prospector.ucsf.edu). Other LEA proteins
have been identified in a proteomic analysis on postdiapaused embryonic development in
A. franciscana and were annotated based on matches within an in-house generated
database containing 30,000 ESTs [11].
The A. franciscana mRNA for group 1 LEA is detected in diapaused embryos but
not in swimming larvae [12]. While only encysted embryos are able to withstand
desiccation for years, this implies a role of group 1 LEA protein in dessication tolerance.
The identification of a unique 21 kDa protein by MS-based approach, in particular the de
novo peptide sequence assignment to tandem motif, allowed cloning and characterization
of the first group 1 LEA protein in animal species. A. franciscana group 1 LEA protein
might be one of the still many missing pieces from the complex puzzle, which this
organism has developed in order to protect their embryos from stressful environmental
conditions.
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CHAPTER 3

Identification of PDI redox sensitive thiols by ICAT-based MS

This chapter incorporates the outcome of joint research undertaken in collaboration with
Inga Sliskovic under the supervision of Dr. Bulent Mutus, Department of Chemistry and
Biochemistry. The collaboration is covered in Chapter 3 of the thesis. In all cases, the
key ideas, primary contributions, experimental designs, data analysis and interpretation,
were performed by the authors, and the contribution of co-authors was primarily through
the provision of recombinant purified protein disulfide isomerase, PDI. Inga prepared the
PDI protein sample in a reduced and auto-oxidized form. Dr. Eric Simon and Dr. Philip
Andrews at the Michigan Proteome Consortium, University of Michigan, provided
knowledge and instrumentation for the peptide separation and MALDI TOF/TOF
analysis. My contribution to this manuscript was application of the isotope-coded affinity
tag (ICAT) technology and identification of the cysteine redox state on PDI using mass
spectrometry (MS). I performed all experimental steps involved in the ICAT labeling
protocols, followed with acquisition and interpretation of the MS spectra.

The results were published: Kozarova, A., Sliskovic, I., Mutus, B., Simon, E.S., Andrews,
P.C., and Vacratsis, P.O. (2007). Identification of redox sensitive thiols of protein
disulfide isomerase using isotope coded affinity technology and mass spectrometry. J Am
Soc Mass Spectrom 18, 260-269
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Introduction
Protein disulfide isomerase (PDI), a member of the thioredoxin superfamily of
redox proteins, is an enzyme responsible for disulfide bond formation and isomerization
[1, 2], redox-dependent chaperone function [3, 4] and S-nitrothiols denitrosation activity
[5]. Originally, PDI was identified in the lumen of the endoplasmatic reticulum [6, 7] and
subsequently detected at additional locations, such as the cell surface and the cytosol [8].
In the case of secreted PDI, it has been demonstrated to control the redox state of certain
cell-surface proteins [9]. Furthermore, PDI was identified as a subunit of prolyl 4hydroxylase [10, 11] and microsomal triglyceride transfer protein [12, 13], executing
different functions than in its monomeric state.
PDI comprises four domains, a, b, b' and a' [14] and an acidic region designated c
[15-17] (Figure 1A). The two thioredoxin domains of PDI [18], a and a', each contain an
active site with a consensus sequence WCGHCK, which are separated by two
thioredoxin-like domains b and b'. The multi-domain structure of PDI is required to
catalyze thiol-disulfide exchange events and effect folding by inducing conformational
changes in the substrate protein [19]. Recently, the crystal structure of yeast PDI was
elucidated and the structure revealed thioredoxin domains arranged in a shape of a twisted
"U" with the active sites facing each other across the "U" [20].
Each PDI molecule contains six cysteine residues. Four of them have been shown
to be responsible for the redox activity and are present as two vicinal thiol groups within
each active site. Multiple studies have investigated the relative redox/catalytic
contributions of the two thioredoxin active sites, and have suggested that they do not have
equivalent catalytic properties [16, 21]. Furthermore, the NMR structure of human PDI a
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domain identified the N-terminal cysteine residue, Cys-36, as accessible and exposed
while the C-terminal cysteine residue, Cys-39, as buried and constrained [22]. In addition,
the crystal structure of yeast PDI predicted that the two cysteines within the a domain are
primarily in the oxidized state (modeled as a mixture of oxidized to reduced state at 0.8 to
0.2 respectively) and the cysteines within the a' domain are in a reduced state [20]. The
function and regulation of the redox states of the other two cysteine residues present
within the b' domain of human PDI, remains unclear.
The redox state of active site cysteines dictates the catalytic activity of PDI.
Opposite redox states are required to facilitate either oxidation or isomerization reactions,
i.e. the best oxidases having the least stable disulfides and the best reductases having the
least stable dithiols [1, 21, 23]. Therefore the thiol/disulfide exchange within the active
site is required for effective oxidation or disulfide formation on PDI substrates [23].
Furthermore, alterations of the redox state balance of PDI underlie different pathological
conditions. For example, it has been observed, that upon activation/aggregation of resting
platelets the amount of reduced cell surface PDI increased approximately three fold, thus
implying that thiol groups are critical for platelet aggregation [24].
Common approaches to analyze thiol oxidation states include spectrophotometric
and fluorescence-based assays [25], however these only provide information regarding
the average number of modified cysteine residues, not their exact identity. Here, we
present a method that uses isotope-coded affinity tag based method (ICAT) in conjunction
with mass spectrometry (MS) [26, 27] to directly detect and quantitate dynamic changes
in the thiol oxidation state of recombinant human PDI under reducing and auto-oxidizing
conditions. In addition to the detection of the redox status of the active site cysteines, we
will offer data indicating redox regulation of Cys-295 present within the b' domain. Also,
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a novel oxidation modification on an invariable tryptophan residue, Trp-35, adjacent to
the cysteine residues within the active site, will also be presented.

Materials and Methods

Purification of Protein Disulfide Isomerase
His-PDI was expressed and purified as described previously [5]. Protein quantification
was performed using the Bradford assay [28] and protein purity was ascertained by SDSPAGE.

PDI reduction and spontaneous auto-oxidation
Bacterially expressed human His-PDI (100 u.g) was fully reduced with 5x molar excess of
DTT for 2 hr at room temperature. The DTT was removed during gel filtration on
Sephadex G-25 in lOOmM phosphate buffer, pH 7. Immediately after separation, the
reduced PDI was acetone precipitated and labelled with light 12C-ICAT reagent (Applied
Biosystems). For spontaneous auto-oxidation, PDI was incubated for 1 hr at room
temperature following the reduction with DTT and gel filtration. Subsequently, this
sample was also acetone precipitated and labelled with heavy 13C-ICAT reagent (Applied
Biosystems).

ICA T labelling of reduced and auto-oxidized PDI
PDI containing samples were prepared as described above and ICAT labelling and
purification of labelled peptides was performed following the provided protocol from
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Applied Biosystems. Briefly, reduced and auto-oxidized PDI was labelled with 12C-ICAT
and

13

C-ICAT reagents, respectively, for 2 hr at 37°C.

After alkylation with the

iodoacetamide-based ICAT reagent, the two samples were mixed together and subjected
to digestion with Endoproteinase Glu-C for 12 hr at 25°C. Peptides were desalted using a
cation exchange cartridge and biotin labelled peptides were purified using an avidin
affinity cartridge provided by Applied Biosystems. Peptides were subsequently dried and
resuspended in the cleavage reagent in order to release the labelled peptides from the
biotin moiety by incubation for 2 hr at 37°C. Subsequently, peptides were dried and
resuspended in 1% formic acid. All samples were desalted using micro-Cis ZipTips
(Millipore) prior to MALDI MS analysis.

HPLC separation of ICAT labelled peptides
ICAT labelled peptides were separated on a LC Packing nanoflow HPLC system (nanoLC) (LC Packings) with a Zorbax 300 SB Cis column (75(4,m x 150mm, 3.5um particles)
(Agilent technologies) at a flow rate of 300 nl/min. These peptides were separated using
multi-step linear gradient of 0 to 30% B in the first 10 min, followed by 30 to 45% B for
37 min, 45 to 60% B for 5 min and 100% B for 6 min (mobile phase A, 3% acetonitrile,
0.1% trifluoroacetic acid; mobile phase B, 90% acetonitrile, 0.1% trifluoroacetic acid).
Column effluent was mixed with MALDI matrix (2mg/ml a-cyano-4-hydroxycinnamic
acid, lOmM ammonium dihydrogen phosphate in 50:49:1 water/isopropyl alcohol/acetic
acid) through a mixing tee and spotted automatically with a Probot (LC Packings) onto a
192-well MALDI target plate. The matrix was delivered to the mixing tee at a flow rate of
1.2 uL/min.
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Mass spectrometry analysis
ICAT labelled peptides were analyzed by MALDI-TOF MS (DE-Pro Voyager, Applied
Biosystems)

and

MALDI-TOF/TOF

(4700

Proteomics

Analyzer,

Applied

Biosystems/MDX Sciex). For the MALDI-TOF MS analysis, the purified labelled peptide
sample (1:1 matrix solution a-cyano-4-hydroxycinnamic acid) was spotted onto a
MALDI target plate and analyzed in reflector mode. For the MALDI-TOF/TOF analysis
MS and MS/MS spectra were acquired in positive ion reflector mode. MS survey scans
were acquired first for each MALDI well and the ions of interest were selected for
MS/MS analysis.

Results and Discussion

ICAT labelling of PDI
An ICAT-labelling approach in combination with mass spectrometry was
developed for the purpose of quantitating changes in the redox state of human His-PDI
under various conditions, since only free thiols will react with the iodoacetamide-based
ICAT reagent. Bacterially expressed human PDI was purified to near homogeneity by
nickel chromatography (Figure IB). To assess if PDI can be labelled with ICAT reagent,
following reduction with excess reducing agent, the free thiol groups on cysteine residues
(cysteine-SH) were incubated with acid-cleavable light

12

C-ICAT reagent. The ICAT-

labelled protein was digested with Glu-C in order to generate unique peptides
corresponding to each active site. The [MH+] 2147 m/z ion represents the peptide
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containing the active site within the a domain, FYAPWC36GHC39KALAPE, containing
two ICAT labels (molecular mass 227 Da per one ICAT-tag) (Figure 2A). This indicates
that both cysteines within the a domain were in the reduced state and thus susceptible to
labelling with the ICAT alkylating agent (confirmed by analysis of MS/MS fragment ion
series, as described below). Importantly, we did not detect a peak at [MH+] 1924 m/z,
which would correspond to only one ICAT-labelled cysteine residue. Similarly to the a
domain active site, a peptide fragment representative of the a' domain active site at
[MH+] 2916 m/z was modified with two ICAT labels. However, further analysis was
complicated with the inability of reproducibly detecting this peptide. Thus, this implies
that under these conditions, cysteine residues within the a' domain peptide
FYAPWC380GHC383KQLAPIWDKLGE, exist predominantly in their oxidized form and
are therefore less susceptible to ICAT modifications.
In addition, peptide fragments corresponding to the two remaining cysteine
residues of the PDI within the b' domain were also detected (Table 1). Numerous
peptides were detected encompassing the ICAT-labelled cysteine at position 295,
specifically EC295PAVRLITLE ([MH+] 1470 m/z) and two peptides corresponding to
additional mis-cleavages ([MH+] 1729 m/z and [MH+] 2579 m/z). The [MH+] ion
detected at 1178 m/z corresponded to the other cysteine within the b' domain, Cys-326,
within the FC326HRFLE peptide.
Mass spectrometric studies to analyze PDI have been performed in the past. An
alternative to the ICAT-based labelling method is alkylation of the cysteine residues with
N-ethylamaleimide (NEM) [29]. In parallel to the ICAT labelling described herein, we
also modified fully reduced PDI with NEM. Fragments corresponding to active sites
modified with one or two NEM adducts (125 Da per NEM label) were detected (data not
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share a common thioredoxin fold, but only the a and a' domain have the WCXXC active
site. Position of all six cysteine residues within human PDI is highlighted. (B) Bacterially
expressed, purified human His-PDI was separated using SDS-PAGE (10%) and
visualized by commassie blue stain. Lane 1 PDI control purchased from Sigma, lane 2
reduced His-PDI (treated with 5x excess DTT), lane 3 auto-oxidized His-PDI (following
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Schematic presentation of ICAT labelling protocol. PDI was reduced and immediately
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corresponds to the Cys-326 present in the b' domain while fragments at [MH+] 1470 m/z,
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Mass (monoisatopic) 12C-ICAT-modified 12C-I CAT-modified
(mte)
(m/z) calculated (m/z) observed

# Start End Cys

Sequence

1
2
3
4

FCHRFLE
ECPAVRLULE
ECPAVRLITLEEE
FYAPWCGHCKALAPE
FFGLKKEECPAVRLrTLEEE

C

6

325
294
294
31
2S7

331
304
306
45
306

951.5
1243.6
1501.8
1692.7
2351.2

1178.6
1470.7
1728.9
2147.0
2578.3

1178.fi
1470.9
1729.0
2147.1
2579.3

375 395 380,383 FYAPWCGHCKQLAPIWDKLGE 2462.2

2916.4

2916.2

326
295
295
36,39
295

Table 1. Recombinant human PDI ICAT-labelled peptides
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shown). In contrast, the ICAT-modified peptides reproducibly produced only peptides
labelled on both cysteine residues. Another cysteine alkylating reagent, the episulfonium
ion derived from S-(2-chloroethyl)glutathione (CEG) has been identified to modify only
one cysteine residue within each active site of rat PDI, the N-terminal residues Cys-36
and Cys-380 [30]. In addition, cysteine residues of PDI were indicated to be modified by
the thiol reactive lipid aldehyde 4-hydroxynonenal (4-HNE) in rat livers fed a
combination of high-fat and ethanol diet [31], although the modified cysteines were not
resolved. Overall, these different thiol reactivities may be due to incomplete labelling
caused by various degrees of hydrophobicity and hydrophilicity of the modifying reagent,
resulting in limited access to buried and solvent inaccessible regions within PDI. Our
results indicate that the structural nature of the ICAT reagent is capable of reacting with
all of the cysteine residues of PDI when they are present in their free thiol form.
Further analysis of the peptide corresponding to the a domain active site indicated
two sequential peaks (each 16 Da apart) in addition to the peak analogous to the
monoisotopic mass of [MH+] 2147 m/z (Figure 2B). These modified light-ICAT labelled
peptides would likely complicate the analysis when light and heavy ICAT-modified
samples were to be compared. Specifically, the second generation ICAT reagents, 12C(light, addition of 227 Da per one ICAT-tag) and 13C-(heavy, addition of 236 Da per one
ICAT-tag), have been designed to differ by 9 Da per cysteine residue for quantitation
purposes [27]. This would result in an addition of 18 Da when two ICAT labelled
cysteines are present within the active site in the a domain. Therefore due to isotopic
interference, the discrimination between the +16 Da (light ICAT-label and modified
peptide ([MH+] 2163 m/z)) and the + 18 Da (heavy ICAT-label and unmodified peptide
([MH+] 2165 m/z)) would be challenging.
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In order to resolve this issue, ICAT-labelled peptides were fractionated using
reverse-phase chromatography (Figure 3). The column elution profile indicated that all of
the modified peptides were significantly resolved from each other (Figure 3a), and in
expected order. The peptide corresponding to the active site within the a domain labelled
with 2 light ICAT-tags and modified by +32 Da eluted first (Figure 3b), followed by the
peptide modified by +16 Da (Figure 3c), whereas the most hydrophobic, non-modified
peptide eluted last (Figure 3 c).

Tryptophan oxidation adjacent to the active site cysteine
MS/MS analysis identified the peptide at [MH+] 2147 m/z to correspond to the a
domain active site fragment, FYAPWC36GHC39KALAPE. This peptide contains two
ICAT labels, one per cysteine residue, as determined from the y6-yio series, the yn
fragment and the bg,bio-bi4 series (Figure 4A). Further analysis of the fragment ion series
indicated that the modified residue on the peptide at 2163 m/z and the peptide at 2179 m/z
was Trp-35. Specifically, the addition of+16 Da ([MH+] 2163 m/z) was identified as
tryptophan monooxidation (hydroxytryptophan) (Figure 4B) and the addition of +32 Da
([MH+] 2179 m/z) was due to the tryptophan dioxidized form (JV-formylkynurenine)
(Figure 4C).
This is an intriguing modification since Trp-35 is located within the a domain
active site immediately adjacent to the active site cysteines. Moreover the modified forms
of the peptide were present in greater yield than the unmodified form (Figure 2). It is
possible, that this modification was the result of MS sample preparation. However, it has
been argued that tryptophan oxidation is not a considered mass spectrometry encountered
artifact, like methionine oxidation [32, 33] and guanidination [34]. Additionally, doubly
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oxidized tryptophan was identified in a subset of mitochondrial proteins predominantly
associated with redox metabolism [33] and in the chaperone a-crystallin from bovine lens
tissue exposed to Fenton chemistry [35]. Sequence analysis of the residue surrounding
Trp-35 within PDI suggests similarity with these other proteins modified in vivo by
tryptophan oxidation. In addition, the location of this tryptophan residue immediately
adjacent to the active site cysteines suggests that tryptophan oxidation may play a role in
regulating PDI catalysis.

Dynamic changes in the redox state of PDI active site
We have previously shown that PDI undergoes auto-oxidation in the absence of
reducing agents [5]. In order to further characterize and definitively identify the cysteine
residues altered during auto-oxidation, the ICAT strategy was used to quantify changes in
the redox state of PDI. Specifically, reduced PDI was labelled with the light 12C-ICAT
reagent, while auto-oxidized PDI was labelled with the heavy 13C-ICAT reagent (Figure
1C). These samples were subsequently combined and processed together. Upon
fractionation of PDI peptides by nano-LC, the relative quantity of thiol oxidation was
assessed by MS. For the purified a domain peptides, all modified forms displayed
approximately a 5 to 1 ratio between reduced and auto-oxidized samples (Figure 5). The
ratio of non-modified tryptophan containing peptides labelled with ICAT-light reagent
(([MH+] 2147 m/z) can be compared to non-modified tryptophan containing peptides
labelled with ICAT-heavy reagent ([MH+] 2165 m/z) (Figure 5C). The ratio of the light
and heavy ICAT labelled hydroxytryptophan containing peptides ([MH+] 2163 m/z and
[MH+] 2181 m/z) was consistent to the unmodified peptides (Figure 5B) as was the case
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Trp ([MH+] 2147 m/z and 2165 m/z) (C) were detected for reduced PDI and autooxidized PDI displaying similar auto-oxidation patterns.
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of N-formylkynurenine containing peptides ([MH ] 2179 m/z and [MH+] 2197 m/z)
(Figure 5A).

Redox-induced changes ofb' domain cysteines
So far, the functional significance of the two cysteine residues within the b'
domain of the human PDI has not been completely elucidated. Point-mutation studies
indicate that these residues do not play any role in PDI catalytic activity or substrate
interaction [19, 36-38]. We observed, that auto-oxidation does not have any effect on
Cys-326, within the sequence FC326HRFLE ([MH+] 1178 m/z and [MH+] 1187 m/z), and
therefore serves as an internal control for the reduced and auto-oxidized samples (Figure
6).
Interestingly, auto-oxidation induced changes in the redox state of the other b'
domain cysteine residue, Cys-295. Two differential cleavage peptides containing Cys-295
([MH+] 1470 m/z and [MH+] 1479 m/z; [MH+] 1728 m/z and [MH+] 1737 m/z)
demonstrated a dramatic loss of ICAT reactivity under auto-oxidized conditions (Figure
6). This result suggests, that in addition to changes within the a domain active site of
human PDI, Cys-295 within the b' domain is also sensitive to redox regulation.
The ICAT-based approach used in this study indicated redox regulation of one of
the two cysteine residues within the b' domain. Specifically, the ability to modify Cys295 with ICAT-reagent upon auto-oxidation decreased about five fold. In contrast, Cys326 remained susceptible to ICAT-labelling even after auto-oxidation, thus implying that
this cysteine residue remains in thiol form. This is interesting since a study involving
chemical modification of an isolated b' domain indicated that neither of these cysteine
residues are likely to exchange between dithiol and disulfide states upon modulation of
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MALDI-TOF analysis of peptides containing b' domain Cys residues labelled with light
and heavy ICAT. Similar levels of peptides containing Cys-326 from reduced (light
ICAT) and auto-oxidized (heavy ICAT) samples were detected at [MH+] 1178 m/z and
[MH+] 1187 m/z respectively. The Cys-295 containing peptides from two mis-cleavage
products ([MH+] 1470 m/z and [MH+] 1728 m/z for light ICAT) show a five fold decrease
in ICAT-labelling upon auto-oxidation ([MH+] 1479 m/z and [MIT"] 1737 m/z).
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redox potential [37]. In contrast, based on the crystal structure of yeast PDI, Cys-90 and
Cys-97, were elucidated to form a disulfide bond [20]. These two non-active site
cysteines are part of the a domain of yeast PDI (unlike the b' domain of human PDI) and
are believed to destabilize the oxidated state of the a domain active site cysteines [39].
Our results using full length PDI implicated Cys-295 as an additional redox sensitive site,
potentially capable of modulating PDI activities.
This study reports direct detection and conclusive identification of redox induced
changes on the cysteine residues of recombinant human PDI in the a, b' and a' domains
using ICAT methodology combined with mass spectrometry. The ICAT data presented
here agree with the predicted susceptibility to oxidation of the active site vicinal thiols
within the a domain, in that both of these cysteine residues were reactive towards ICATreagent in the fully reduced enzyme. However, the ICAT-signal of these thiols decreased
by five fold upon auto-oxidation. In contrast, the a' active site cysteine residues could not
be reliably labelled with ICAT-reagent, and are thus probably present in an oxidized state.
This is in accordance with the decrease of total cysteine content upon auto-oxidation as
determined by reactivity with 5,5'-dithiobis(nitrobenzoic acid) [5]. In conclusion, PDI
activity is redox dependent and regulated; therefore we developed a method to study
direct dynamic changes in the redox state of PDI.
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CHAPTER 4

Identification of hYVHl phosphorylation sites by MS and their function

This chapter incorporates the outcome of joint research undertaken in collaboration with
Dr. John W. Hudson, Department of Biological Sciences. The collaboration is covered in
Chapter 4 of the thesis. In all cases, the key ideas, primary contributions, experimental
designs, data analysis and interpretation, were performed by the authors, and the
contribution of co-authors was through the provision of experimental help, analysis and
data interpretation with flow cytometry based approach. My contribution to this
manuscript in preparation was identification of phosphorylation sites on Flag-hYVHl
expressed and immunoprecipitated from mammalian cells; generation of phosphomutants,
localization experiments, RNAi experiments and characterization of the phenotype, as
well as sample processing for flow cytometry experiments.
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Introduction
Protein phosphorylation (by protein kinases) and dephosphorylation (by protein
phosphatases) is a universal regulatory mechanism controlling a vast array of signalling
pathways and physiological processes [1-4]. Dual specificity phosphatases (DUSPs)
encompass a group of heterogeneous and versatile enzymes that are able to remove
phosphate moieties from phosphotyrosine and phosphoserine/threonine residues [5]. The
best characterized role of DUSPs is the regulation of proline directed kinase families such
as the mitogen activated protein kinases (MAPKs) and the cyclin dependent kinases
(CDKs).
Atypical dual specificity phosphatases represent a DUSP subfamily and consist of
generally smaller enzymes (only three members of this subgroup are bigger than 27 kDa),
and lack the N-terminal Cdc25 homology 2 domain (which is typical for DUSPs) [5].
Therefore, it is postulated that most atypical DUSPs are not direct regulators of MAPKs
or CDKs. Furthermore, certain atypical DUSPs contain unique domain architectures that
likely dictate distinctive cellular functions; e.g. laforin contains a carbohydrate binding
domain [6], DUSP 11 has arginine- and proline-rich regions [7] and DUSP 12
encompasses a zinc binding domain [8, 9].
Human YVHl, (hYVHl, DUSP 12) contains a conserved N-terminal catalytic
domain and a novel C-terminal zinc-binding domain [9]. Thus it is not surprising, that
upon clustering analysis of human atypical dual specificity phosphatases, hYVHl appears
on a separate branch of the dendogram [10]. Disruption of yeast DUSP 12 (YVHl) causes
a slow growth phenotype [11], which can be complemented by the human orthologue
(hYVHl), or a mutant containing a catalytically inactivating version of hYVHl (hYVHl C115S). This ability to rescue the mutant phenotype is lost upon deletion of the C87

terminal zinc binding domain [9]. Additional phenotypes due to deletion of YVHl in
yeast include defects in glycogen metabolism and spore maturation [12]. A yeast twohybrid screen identified YPH1 (yeast pescadillo homo log, Nop7) as a yeast YVHl
interacting partner [13]. Nop7 is required for multiple activities during 60S ribosomal
synthesis [14]. Interestingly, YVHl was also recently identified as a 60S trans-acting
factor in a mass spectrometry (MS)-based analysis of pre-60S particles [15]. It was
further shown that interplay between YVHl and Mrt4 is required for the late maturation
step of the 60S subunit [16, 17], thus highlighting the role of YVHl in the ribosomal
biogenesis pathway.
Human YVHl was found by a MS-based approach to interact with Hsp70 [18].
Over-expression of hYVHl repressed cell death induced by cellular insults, such as heat
shock, hydrogen peroxide exposure and Fas receptor activation. This repression is further
enhanced upon co-expression with Hsp70 [18]. Also, a role for hYVHl in tumourigenesis
is supported by a recent clinical study, in which hYVHl was shown to be selectively and
highly overexpressed in CD34+ progenitor cells from chronic myelogenous leukemia
patients [19]. However, hYVHl remains a poorly understood phosphatase especially
regarding how its activities are regulated in the cell.
Here we report the first identified phosphorylation sites within hYVHl using a
MS based approach. The sites were further characterized in terms of their effect on
hYVHl localization and DNA content of cells over-expressing the phosphomimetic and
non-phosphorylatable mutants. In addition, the cell cycle phenotype observed due to
down-regulation of hYVHl is also described.
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Materials and methods

DNA plasmids
Flag-hYVHl and C115S were described previously [9]. Domain specific
constructs, i.e. Flag-hYVHl,.192 (ACTl), Flag-hYVHl,.26g (ACT2), Flag-hYVHli.282
(ACT3), and Flag-hYVHl ,93.340 (Zn-binding domain) were described previously [18].
The mutants S335A and S335E, were generated by replacement of hYVHl amino
acids sequence 331-340 flanked by Sspl and BamHI sites with synthetic oligonucleotide
duplexes containing the mutation, sequences as follow; for S335A oligol 5'ATTGCCTG
TTTTGGGAGCACAAACAGGAAAGATCTGAG 3', oligo2 5'GATCCTTCAGATCTT
TCCTGTTTGTGCTCCCAAAACAGGCAAT 3'; for S335E oligol 5'ATTGCCTGTTT
TGGGAGAACAAACAGGAAAGATCTGAG 3' and oligo2 5'GATCCTCAGATCTTT
CCTGTTTGTTCTCCCAAAACAGGCAAT 3'.
The S14A and S14E mutations were introduced using the QuikChange sitedirected mutagenesis kit (Stratagene). Primers are as follows, for S14A primer 1
5'GATGGCTGCGAGCTCGCCAACCCCAGCG 3', primer2 5'CGCTGGGGTTGGCG
AGCTCGCAGCCATC 3'; and for SHE primerl 5'GATGGCTGCGAGCTCGAGAAC
CCCAGCGCCAG 3' andprimer2 5'CTGGCGCTGGGGTTCTCGAGCTCGCAGCCAT
C 3'. Multiple mutations were introduced in stepwise manner using the site-directed
mutagenesis approach.
Flag-hYVHl phosphomimetic TP mutants were generated by QuickChange sitedirected mutagenesis kit (Stratagene) following the manufacturer protocol. Primers are as
follows, for T252A primerl 5'GCCCACAAGAGAATGGCACCATCTTCCATG 3',
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primer2 5'CATGGAAGATGGTGCCATTCTCTTGTGGGC 3'; and for T252E primerl
5 'CCCACAAGAGAATGGAACCATCTTCCATGCTTACCAC 3', primer2 5' GTGGT
AAGCATGGAAGATGGTTCCATTCTCTTGTGGG 3'.
All mutations were verified by DNA sequencing.

Tissue culture, transfections and treatments
HEK 293 (ATCC) cells were maintained in Dulbecco's modified eagle's medium
nutrient mixture F-12 HAM (Sigma) supplemented with 10% fetal bovine serum (FBS,
Sigma) and 2mM glutamine (Gibco); HeLa cells (ATCC) were grown in DMEM
(Thermo Scientific) containing 10% FBS at 37°C and 5% C0 2 . Transient transfections
were performed either by Fugene HD (Roche) following manufacturer directions or by
calcium phosphate method [20] for 24-48 hr. For treatment with phosphatase inhibitors,
cells were exposed to calyculin A (Cal A; lOOnM; LC Laboratories) for 30 minutes,
okadaic acid (OA; 5uM; LC Laboratories) for 30 minutes, cyclosporin A (CsA; lOuM;
LC Laboratories) for 24 hr or dimethylsulphoxide (solvent), prior to lysis.
For MAPK inhibitors, cells were treated with SB 203580 (lOuM, LC
Laboratories), SP600125 (40uM, LC Laboratories), U0126 (lOuM, LC Laboratories) for
1 hr prior to lysis. For combination experiments, first cells were treated with MAPK
inhibitors for 30 min prior to addition of Cal A, and then both inhibitors were incubated
together for an extra 30 min.
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Immunoprecipitation

experiments

Transfected cells were lysed in 50mM Tris 7.5, 150mM NaCl, 1% Triton X-100,
0.1% SDS containing 100 ug.ml"' aprotinin, ImM phenylmethylsulphonyl fluoride and
50mM sodium fluoride, and then centrifuged at 20,000g for 30 minutes at 4°C. The
cleared cell lysates were incubated with pre-equilibrated anti-Flag M2 agarose (Sigma)
for 3 hr, followed by three washes in wash buffer (50mM Tris 7.5, 150mM NaCl, 0.1%
Triton X-100, 0.1% SDS). For dephosphorylation experiments, immunoprecipitated FlaghYVHl was treated with 30U calf intestinal alkaline phosphatase (CIP, Promega) for 30
minutes at 37°C. Proteins were resolved on 10% SDS-PAGE gels and stained first with
Pro-Q Diamond phosphoprotein stain (Molecular Probes) using manufacturer provided
protocol and visualized on Molecular Imager FX (Bio-Rad). Thereafter, gels were either
silver stained [21] or coomassie brilliant blue G stained.

Preparation of phosphopeptides and MS analysis
Peptides were prepared by in-gel digestion of immunoprecipitated Flag-hYVHl
separated on SDS-PAGE gel [22]. Briefly, bands corresponding to Flag-hYVHl were
excised and incubated in destain solution (50% acetonitrile, ACN, HPLC-grade Burdick
& Jackson, and 50% 50mM ammonium bicarbonate, Fisher) for 35 minutes at 37°C.
Afterwards, gel pieces were dehydrated in 100% ACN and dried for 20 minutes in a
speed vac. Protein were digested with either Endoproteinase GluC (Roche) or sequencing
grade modified trypsin (Promega) following manufacturer directions. Peptides were
collected by extraction with 60% ACN and 1% formic acid. Collected peptides were
desalted on C,g ZipTip (Millipore) or Cis spin columns (Vivascience) following
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manufacturers supplied protocol prior to MALDI-TOF analysis (Applied Biosystems
Voyager, DE PRO instrument).
In order to enrich for low abundance phosphopeptides, desalted peptides were
subjected to PHOS-select™ Iron Affinity Gel (Sigma), using the manufacturer provided
protocol. Briefly, peptides were incubated with pre-equilibrated bead slurry (in 250mM
acetic acid, 30% ACN). Non phosphorylated peptides were removed (250mM acetic acid,
30% ACN) and phosphopeptides were eluted (400mM ammonium hydroxide). Samples
were desalted as describe above. Peptides were mixed with matrix (10 mg/ml a-cyano-4hydroxycinnamic acid in 60% ACN and 1% formic acid), and spotted onto MALDI-plate.
MS instrument was calibrated with Sequazyme peptide mass standards kit (Applied
Biosystems). The peptide finger-print was acquired in positive linear mode, with the
accelerating voltage set to 25,000V, grid voltage set to 94%, guide wire to 0.05% and the
extraction delay time to 100 nsec. Spectra were analyzed using the Data Explorer
Software (Applied Biosystems). Experimental peptide masses were compared to
theoretical values calculated by ProteinProspector MS-Digest Program (available at
http://prospector.ucsf.edu).

siRNA experiments
Endogenous hYVHl was down-regulated by transfection with Lipofectamine
RNAiMAX (Invitrogen) of Stealth siRNA duplex oligonucleotides (CCUGGAAACUAU
GCUUUACAUGGCA; Invitrogen) for 48 hr, following manufacturer provided protocol.
As a negative control, cells were transfected with Stealth RNAi Negative universal
control low GC duplex #3 (Invitrogen). Prior to immunoblot analysis, Bradford assay

92

(BioRad) was performed to determine the total amount of proteins in pre-cleared lysates.
Proteins resolved on SDS-PAGE were transferred electrophoretically to PVDF
membrane, which were probed with optimal dilutions of primary antibodies (endogenous
anti-hYVHl [9], anti-actin (Sigma)), followed by secondary antibody (anti-rabbit HRP,
BioRad). Antibody conjugates were detected by SuperSignal west femto maximum
sensitivity substrate (Thermo Scientific) according to manufacturer's directions.

Immunofluorescence analysis
HeLa cells grown on glass cover-slips were fixed in phosphate-buffered saline
(PBS) containing 3.7% paraformaldehyde and 0.1% Triton X-100 for 12 minutes at room
temperature. After washing with PBS, cells were permeabilized in PBS containing 0.1%
Triton X-100 for 2 minutes at room temperature. Prior to incubation with antibodies, cells
were blocked by 10% BSA for 30 minutes at 37°C. Cells were the incubated with antiFlag M2 monoclonal antibody (Sigma) at 1:500 in Tris-buffered saline containing 0.1%
Tween-20 (TBST) for 1 hr at room temperature, followed by washes in TBST. Primary
antibody was visualized by incubation with fluorescein-conjugated anti-mouse (Vector
Labaratories) at 1:500 for 30 minute at room temperature. DNA was counterstained with
Hoechst 33342 (Molecular Probes) prior to mounting with SlowFade Antifade (Molecular
Probes). Images were acquired on Zeiss Axioskop 2 (motplus) microscope equipped with
Qlmagin Qcam camera and analyzed with Northern Eclipse software.
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Flow cytometry analysis
Adherent HEK 293/HeLa cells expressing Flag-hYVHl and various mutants were
trypsinized (Sigma) and cells were harvested by centrifugation at 50g for 5 minutes.
Pelleted cells were first resuspended in a PBS wash, harvested by centrifugation, then
fixed overnight in ice cold 80% ethanol. Cells were then pelleted by centrifugation at
300g for 5 minutes, washed in PBS and then 1% BSA in PBS. Cells were permeabilized
in 0.25% Triton X-100 in PBS for 5 minutes at room temperature, then PBS was added
prior to next centrifugation step. Transfected cells (for over-expression experiments) were
identified by staining with anti-Flag M2 monoclonal antibody (1:100) for 1 hr at room
temperature, followed by 1% BSA in PBS wash and detected by a horse anti-mouse
fluorescein antibody (1:30). siRNA transfected cells (down-regulation experiments) were
identified by a lack of staining with endogenous anti-hYVHl antibody. Cells were stained
as described above, except non-transfected cells were detected by staining with antihYVHl (1:100) and goat anti-rabbit fluorescein (Vector Labaratories) antibodies. After
antibody labelling, cells were washed in 1% BSA in PBS and incubated with RNase A for
30 min prior to addition of propidium iodide (Sigma) for detection of DNA content. As
negative and internal controls, unlabelled sample, singly labelled samples and sample
labelled only with secondary antibody were included. Two-colour analysis was performed
on Cytomics FC500 (Beckman Coulter) using CXP analysis software.

Senescence /3-galactosidase assay
Detection of senescent cells was performed according to the protocol provided with a
senescence P-galactosidase staining kit (Cell Signaling) with minor modifications.
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Briefly, siRNA transfected HeLa cells were washed in PBS and fixed in 2%
formaldehyde for 15 minutes at room temperature. After washing, cells were incubated
overnight at 37°C in freshly prepared solution of 5-bromo-4-chloro-3-indolyl-P-Dgalactopyranoside in 40mM citric acid/sodium phosphate 6.0, 150mM NaCl, 2mM
MgCl2, and 5mM potassium ferricyanide. Cells were visualized on a Zeiss Axiovert 40 CFL
microscope in bright field and images were acquired with MicroPublisher 3.3 RTV camera and Q
Capture acquisition software.

Results

hYVHl is regulated by phosphorylation
In order to elucidate whether hYVHl is regulated by phosphorylation, the total
levels of phosphorylation on Flag-YVHl immunoprecipitated from transiently transfected
cells were analyzed by the fluorescent Pro-Q Diamond phosphostain. This fluorescent dye
detects phosphorylation on serine, threonine and tyrosine residues, and thus after total
protein staining with Coomassie brilliant blue, relative changes in phosphorylation levels
can be quantitated by densitometry. Upon treatment of Flag-hYVHl expressing cells with
the PP1 and PP2A inhibitor calyculin A, total phosphorylation was increased about five
fold. Furthermore, when Flag-hYVHl was immunoprecipitated from cells previously
treated with calyculin A and then incubated with alkaline phosphatase there was a
decrease in the total phosphorylation along with diminished levels of higher molecular
weight species (Figure 1A). The identification of the higher molecular weight band as
Flag-hYVHl

was confirmed by MS analysis (data not shown). In addition to
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Figure 1. Phosphorylation of hYVHl
(A) Flag-tagged hYVHl was immunoprecipitated from HEK 293 cells and total
phosphorylation status was analyzed by staining with Pro-Q Diamond phosphoprotein
stain followed by silver staining. 30 minutes prior to lysis, cells were treated with either
phosphatase inhibitor calyculin A (Cal A; lOOnM) or DMSO (negative control), and
afterwards, immunoprecipitated proteins were dephosphorylated by treatment with calf
intestinal phosphatase (CIP). (B) Transfected cells were treated for 30 minutes prior to
lysis with phosphatase inhibitors Cal A, okadaic acid (OA; 5uM) or 24 hr with
cyclosporin A (CsA; lOuM). Total phosphorylation status was visualized with Pro-Q
diamond stain, followed by Coomassie brilliant blue staining. (C, D) MS-spectra
corresponding to Flag-hYVHl peptide fingerprint generated with endoproteinase GluC
(C) and trypsin (D). Peptides were obtained from in-gel digestion of immunoprecipitated
Flag-hYVHl treated with Cal A prior to lysis. The upper panel is a representative of a
sample prior to phosphopeptide enrichment; the lower panel displays a spectra following
the phosphopeptide enrichment step. Arrows indicate phosphopeptides. Peptide identities
were confirmed by post-source decay analysis (MS-MS).
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calyculin A, treatment with another PP2A phosphatases inhibitor, okadaic acid, caused a
similar effect thus confirming our previous result. Consistent with these observations,
cyclosporin A, a PP2B inhibitor, did not affect the total phosphorylation status of FlaghYVHl (Figure IB).
In order to identify the sites of phosphorylation, a MS-based approach was
employed. Peptides were generated by in-gel digestion with endoproteinase Glu C (Figure
1C) and trypsin (Figure ID) and analyzed by matrix assisted laser desorption/ionization
time of flight (MALDI-TOF) MS. As ionization of phosphopeptides are commonly
suppressed by non-phosphopeptides (upper panels), immobilized metal

affinity

chromatography (IMAC) [23] was carried out to enrich for phosphorylated hYVHl
peptides. IMAC purification followed by MALDI-post source decay analysis allowed us
to identify three hYVHl phosphorylation sites; one within the extreme N-terminal region,
corresponding to residue Serl4, one in the extreme C-terminal region, at amino acid
position Ser335 and one within the Zn-binding domain, corresponding to Thr252 (Figure
1C-D, lower panels). These results are the first reported phosphorylation sites for any
YVHl orthologue and provide an opportunity to learn a fundamental aspect of hYVHl
function and regulation.
Ser 14 phosphorylation affects hYVHl localization and cell cycle progression
Human YVHl has been shown to display a nuclear, perinuclear and cytoplasmic
localization pattern in a variety of cell lines [9, 16, 18] indicating hYVHl exhibits
nuclear/cytoplasmic shuttling. In order to elucidate a potential role of Serl4
phosphorylation on hYVHl localization, we examined the localization patterns of nonphosphorylatable S14A and phosphomimetic S14E mutants in HeLa cells (Figure 2).
Consistent with previous reports, wild type FLAG-hYVHl displayed a nuclear,
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Figure 2. Analysis of hYVHl N-terminal phosphorylation site
(A) Subcellular localization was analyzed in HeLa cells for Flag-tagged hYVHl and nonphosphorylatable and phosphomimetic mutants, SKA and S14E, respectively.
Transfected cells were detected by anti-Flag antibody staining, and were counterstained
with Hoechst 33342. Scale bars represent 15 microns. (B) Cell cycle profile of transfected
cells presented as representative histogram data plots. HEK 293 cells were transfected
with expression vectors encoding either empty vector or Flag-hYVHl (as indicated),
harvested after 48hr, stained for transfected cells, counterstained with propidium iodide
and then subjected to a double colour flow cytometry analysis. (C) HEK 293 cells were
transfected with expression vectors encoding either empty vector, Flag-hYVHl or FlaghYVHl C115S (as indicated), harvested after 48hr, stained for transfected cells,
counterstained with propidium iodide and then subjected to a double colour flow
cytometry analysis. The graph shows the percentage change in cell cycle phase relative to
empty vector control; data shown is a representative of at least three independent
experiments. (D) Cell cycle profile of cells expressing Serl4 non-phosphorylatable and
mimetic mutants presented as representative histogram data plots. Cells were processed as
described in B. (E) The graph displays a percentage change in cell cycle phase of Nterminal mutants relative to empty vector control; data shown is a representative of at
least three independent experiments.
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perinuclear and cytoplasmic localization pattern (Figure 2A). It is noted that hYVHl was
not detectable within the nucleolus and that in most instances the shape of the nuclei in
transfected cells had a distinct morphology in comparison to neighbouring nontransfected cells (Figure 2A). The SKA mutant displayed a mainly nuclear localization
pattern similar to that found with wild-type Flag-hYVHl but more predominant. As with
wild-type over-expression, there were regions lacking staining within the nucleus that
were presumed to be nucleoli. The S14E mutation, on the other hand, was predominately
localized in the cytoplasm, although some nuclear staining was also detected (Figure 2A).
Unexpectedly, we also noted an overall increase in the number of mitotic-like
cells in all hYVHl variants in comparison to the controls transfected with the Flag-empty
vector. In order to further characterize this phenotype, we examined hYVHl overexpression on cell cycle profiles by flow cytometry utilizing a double colour analysis, in
which we gated on cells positive for the presence of individual Flag-hYVHl constructs.
Interestingly, there was a substantial decrease in the percentage of cells in Go/Gi, an
unchanged percentage of cells in S, and a large increase in the proportion in G2/M and
polyploid cells as compared to controls (cells either untransfected or transfected with
Flag-empty vector) (Figure 2B). The enzymatically inactive mutant, Flag-hYVHl C115S,
displayed a similar cell cycle profile to Flag-hYVHl (Figure 2C), thus suggesting that
phosphatase activity is not required for hYVHl's effect on the progression through the
cell cycle. When the DNA content of cells transfected with the S14A mutant was
analyzed, a similar pattern to that for Flag-hYVHl was observed. However, the mutant
mimicking phosphorylation at Serl4 (S14E) caused a more substantial decrease in the
proportion of cells in G0/G1, and an increase in polyploid cells when evaluated against
Flag-hYVHl (Figure 2D-E). Together, these observations indicate that hYVHl over100

expression causes an overall increase in 2N DNA content. Furthermore, an N-terminal
mutant mimicking the phosphorylated residue, S14E displays a marked increase in cells
containing more that 2N DNA content.

Ser335 phosphorylation affects cellular DNA content
In order to assess the functionality of the C-terminal phosphorylation site, nonphosphorylated S335A and phosphomimetic S335E mutations were introduced into FlaghYVHl and their effects on hYVHl localization and cell cycle progression were
analyzed. Similar to the S14A mutant, the S335A mutant mainly displayed a nuclear
localization pattern with some cytoplasmic staining, while the S335E mutant (like S14E)
was predominately present in the cytoplasm (Figure 3A). In addition, over-expression of
the phosphomimetic S335E mutant resulted in cells displaying multiple nuclei. This was
further confirmed using flow cytometry. Cells overexpressing FlagYVHl-S335E
displayed an increase in 2N DNA content i.e. an increase in percentage of cells in G2/M
phase, when compared to Flag-hYVHl expressing cells (Figure 3B-C).
The other phosphorylation site identified within the Zn-binding domain was
Thr252. As a proline is immediately following this phosphorylation site, we asked
whether proline directed phosphorylation at T252 could be regulated by MAPKs. As a
preliminary approach, we tested if various MAPK inhibitors were capable of reducing the
levels of phosphorylated hYVHl in vivo. Flag-hYVHl expressing cells were treated with
MAPK inhibitors, SB 203580 (inhibits p38), SP600125 (an inhibitor of JNK) and U0126
(inhibits ERK through inhibition of its upstream activator MEK) alone or in combination
with calyculin A. Changes in the phosphorylation status of immunoprecipitated proteins
were analyzed by Pro-Q diamond dye. Based on three independent experiments, the total
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Figure 3. Analysis of hYVHl C-terminal phosphorylation site
(A) Subcellular localization was analyzed in HeLa cells for Flag-tagged hYVHl and nonphosphorylable and phosphomimetic mutants, S335A and S335E, respectively.
Transfected cells were detected by anti-Flag antibody staining, and were counterstained
with Hoechst 33342. Scale bars represent 15 microns. (B) Cell cycle profile of transfected
cells presented as representative histogram data plots. HEK 293 cells were transfected
with expression vectors encoding either Flag-hYVHl S335A or Flag-hYVHl S335E (as
indicated), harvested after 48hr, stained for transfected cells, counterstained with
propidium iodide and then subjected to a double colour flow cytometry analysis. (C) The
graph shows the percentage change in cell cycle phase in cells transfected with Cterminal mutants relative to empty vector control; data shown is a representative of at
least three independent experiments.
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phosphorylation status was decreased upon combination treatment with SP600125 and
calyculin A (Figure 4A). This result suggests that JNK could be one of the upstream
regulators of Flag-hYVHl

but requires

further

investigation.

However, this

phosphorylation event has no detectable affect on hYVHl function in terms of
localization and ploidy of cells. When the non-phosphorylated T252A and phosphomimetic T252E mutations were introduced and their ability to affect distribution in the
cell by localization were analyzed, in both cases mainly a nuclear pattern was observed
(Figure 4B). Regions within the nucleus that lacked staining were tentatively identified as
nucleoli. Additionally, the cell cycle profiles of cells expressing these mutants were
indistinguishable from cells transfected with Flag-hYVHl (Figure 4C).
The phosphomimetic mutants, S14E and S335E display localization phenotypes
opposite to those observed for the non-phosphorylatable mutants, S14A and S335A. We
were next interested in determining whether phosphorylation of these sites acts in a
concerted fashion with regards to localization and cell cycle profiles. We therefore
examined the effect of double mutant constructs containing both sites mutated at the same
time (double AA and double EE mutants) as well as mutants of all three identified sites
(triple AAA and triple EEE mutants) on localization (Figure 5A). Not surprisingly, we
found a similar distribution to that previously found for the corresponding single mutants
with the SKA and S335A mutations mainly nuclear with some cytoplasmic staining and
SKE and S335E mutations mainly cytoplasmic.
In contrast, the cell cycle analysis of cells transfected with Flag-hYVHl SKA
S335A (AA) as well as Flag-hYVHl SKA T252A S335A (AAA) showed less of an
effect on the proportion of cells in Go/Gi compared to Flag-hYVHl, and on the
percentage of cells in G2/M and multinucleated. The cell cycle profiles were more
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Figure 4. Analysis of hYVHl TP phosphorylation site
(A) HEK 293 cells were transfected with Flag-hYVHl and treated for lhr prior to lysis
with MAPK inhibitors SB 203580 (lOuM), SP600125 (40uM), U0126 (lOuM) without or
with calyculin A (Cal A). Total phosphorylation status was visualized with Pro-Q
diamond stain, followed by coomassie brilliant blue staining. Densitometry values are
presented as ratios of ProQ/coomassie band intensities; DMSO treated Flag-hYVHl was
assigned an arbitrary value of 1.0. Densitometry values were acquired with ImageJ
software and are representative of at least three independent experiments. (B) Subcellular
localization was analyzed in HeLa cells for Flag-tagged hYVHl and non-phosphorylable
and phosphomimetic mutants, T252A and T252E, respectively. Transfected cells were
detected by anti-Flag antibody staining, and were counterstained with Hoechst 33342.
Scale bars represent 15 microns. (C) HEK 293 cells were transfected with expression
vectors encoding either Flag-hYVHl T252A or Flag-hYVHl T252E (as indicated),
harvested after 48hr, stained for transfected cells, counterstained with propidium iodide
and then subjected to a double colour flow cytometry analysis. The graph shows the
percentage change in cell cycle phase of transfected cells relative to empty vector control;
data shown is a representative of at least three independent experiments.
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Figure 5. Analysis of hYVHl double and triple phosphorylation site mutants
(A) Subcellular localization was analyzed in HeLa cells for Flag-tagged hYVHl and
double and triple non-phosphorylable and phosphomimetic mutants, Flag-hYVHl SKA
S335A (AA), Flag-hYVHl SKA T252A S335A (AAA) and Flag-hYVHl S14E S335E
(EE) and Flag-hYVHl SHE T252E S335E (EEE), respectively. Transfected cells were
detected by anti-Flag antibody staining, and were counterstained with Hoechst 33342.
Scale bars represent 15 microns. (B) HEK 293 cells were transfected with expression
vectors encoding either Flag-hYVHl SKA S335A (AA), Flag-hYVHl SKA T252A
S335A (AAA) and Flag-hYVHl SHE S335E (EE) or Flag-hYVHl SHE T252E S335E
(EEE) (as indicated), harvested after 48hr, stained for transfected cells, counterstained
with propidium iodide and then subjected to a double colour flow cytometry analysis. The
graph shows the percentage change in cell cycle phase of transfected cells relative to
empty vector control; data shown is a representative of at least three independent
experiments.
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comparable to cell cycle profiles of Flag-empty vector than cells expressing Flag-hYVHl.
Thus the triple A mutation abrogates the phenotype caused by over-expression of FlaghYVHl (Figure 5B). Meanwhile, the Flag-hYVHl SHE T252E S335E mutant (EEE)
displays a similar effect on the progression through cell cycle as Flag-hYVHl (Figure
5A).
The zinc binding domain mediates the hYVHl induced cell cycle profile
In yeast, the C-terminal Zn-binding domain is able to complement the slowgrowth phenotype of a yvhl deletion [12, 24], rescue the 60S export defect [16, 17, 24],
and is necessary for glycogen accumulation, growth and spore maturation [12]. In
humans, this domain has a protective function offering intrinsic redox buffering capacity
and is necessary for the cytoprotective function of hYVHl [18, 25]. We therefore tested
the over-expression of the Zn-binding domain as well as three different C-terminal
deletion constructs for their effect on cell cycle progression. The ACTl construct
terminates right after the phosphatase catalytic domain, the ACT2 variant in addition to
the catalytic domain contains the first zinc coordination site, and the ACT3 variant
contains an additional hydrophobic motif, which is highly conserved among orthologues
[18].
The N-terminal catalytic domain (ACTl) essentially had a similar profile as our
Flag-empty vector control, indicating the importance of the zinc binding domain for the
hYVHl cell cycle phenotype. Interestingly, over-expression of both partial (ACT2 and
ACT3) and the complete C-terminal Zn-binding domain resulted in a large decrease in the
population of Go/Gi cells and a large increase in the population of G2/M and polyploid
cells (Figure 6A-B). The strongest effect was found with the entire Zn-binding domain.
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These results strongly suggest that the Zn-binding domain is necessary and sufficient for
hYVHl mediated cell cycle changes.

Knockdown of hYVHl expression blocks cells in Go/Gj and induces cellular senescence
The above experiments demonstrate that over-expression of hYVHl reduces
Go/Gi and increases the percentage of cells in G2/M and the percentage of cells displaying
DNA content greater than 2N. To complement these results, we analyzed the cell cycle
profile of cells that had hYVHl expression knocked down by double stranded small
interfering RNA (siRNA). The hYVHl siRNA oligonucleotide was transfected into both
HeLa and HEK293 cells and resulted in approximately an 80% decrease in hYVHl
expression, while actin levels remained unchanged (Figure 7E). The loss of hYVHl
expression was accompanied by a striking increase in the G0/G1 population of cells and
subsequent decrease in other cell cycle phases (Figure 7A-B). When we gated on cells
that were not expressing hYVHl, approximately 90% of the cells were in G0/G1 (Figure
7A).
Since cells that arrest in G0/G1 for prolonged periods are susceptible to permanent
cell cycle arrest, we were interested in investigating if hYVHl can influence cellular
senescence. Therefore, cells treated with hYVHl siRNA were stained for the senescent
marker p-galactosidase and analyzed at different time periods (Figure 7C). Staining of
hYVHl siRNA treated cells revealed that post seven days siRNA there was a
reproducible increase in the proportion of senescent cells (Figure 7C-D). Coupled to the
over-expression data, these results demonstrate for the first time, that hYVHl is a novel
regulator of cell cycle progression.
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Figure 6. Effect of domain specific constructs on progression through cell cycle
(A) Cell cycle profile of transfected cells presented as representative histogram data plots.
HEK 293 cells were transfected with expression vectors encoding either Flag-hYVHl 1.192
(ACTl), Flag-hYVHl 1.268 (ACT2), Flag-hYVHl,.282 (ACT3), or Flag-hYVHl,93-340 (Znbinding domain) (as indicated), harvested after 48hr, stained for transfected cells,
counterstained with propidium iodide and then subjected to a double colour flow analysis.
(B) The graph shows the percentage change in cell cycle phase in cells transfected with
various domains relative to empty vector control; data shown is a representative of at least
three independent experiments.
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Figure 7. Analysis of hYVHl siRNA
(A) Cell cycle profile of control siRNA treated cells or cells where hYVHl has been
down-regulated by siRNA presented as representative histogram data plots. HEK 293
cells were transfected with either control siRNA or hYVHl siRNA (as indicated),
harvested after 48hr, stained for non-transfected cells (lack of staining with endogenous
hYVHl antibody), counterstained with propidium iodide and then subjected to a double
colour flow cytometry analysis. (B) The graph shows the percentage change in cell cycle
phase in cells where hYVHl has been down-regulated by siRNA relative to control
siRNA; data shown is a representative of at least three independent experiments. (C) pgalactosidase staining of HEK 293 cells transfected with a control siRNA or hYVHl
siRNA. Cells were cultured for two, five and seven days. Arrows indicate positive blue
cells. (D) Graphical presentation of the p-galactosidase staining of senescent cells. Data
shown is a representative of three independent experiments. (E) Anti-hYVHl
immunoblot analysis of untransfected cells, cells transfected with siRNA control and
hYVHl siRNA and corresponding anti-actin immunoblot.
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Discussion

We have discovered that the expression of hYVHl alters the cell cycle profile of
asynchronized HEK 293 cells. While the phosphatase activity seems to be dispensable
for this property, the zinc binding domain is necessary and sufficient to elicit this
response. Although this study is the first report to implicate hYVHl as a cell cycle
regulator, other atypical DUSPs have been suggested to act as important positive and
negative regulators for cell cycle progression. For example, expression of VHR (DUSP3),
has been shown to be most abundant in mitotic cells [26]. Down-regulation of VHR is
accompanied by loss of entry into S phase, thus triggering cell cycle arrest [26]. Downregulation of laforin results in a significant increase in the number of cells at S and G2/M
phases, thus promoting cell growth [27], Similarly, down-regulation of DUSP11, also
results in increased proliferation [28].
IMAC purification coupled to MALDI-TOF MS yielded the first ever identified
phosphorylation sites for any YVHl orthologue. The two phosphorylation sites that
affected hYVHl localization and cell cycle progression are located at the termini of
hYVHl. The location of the phosphorylation sites is not surprising since the termini of
proteins is a common site for protein phosphorylation including cell cycle regulators p53
[29], histone H3 [30] and cdc2 [31]. Since phosphorylation often regulates enzyme
activity, we did initially examine if these sites affected phosphatase activity. However,
we saw no difference in phosphatase activity upon treatment with calyculin A using the
exogenous fluorescent substrate DiFMUP (data not shown). Instead, our results suggest
that both the N-terminal Serl4 and C-terminal Ser335 phosphorylation sites play a role in
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regulating the subcellular localization of hYVHl and in augmenting the cell cycle
phenotype exhibited by hYVHl over-expression.
Analysis of the conservation of the phosphorylation sites amongst YVHl
orthologues suggests that regulatory phosphorylation may be specific for mammalian
orthologues. In particular, the Serl4 phosphorylation site within the N-terminal region of
hYVHl is not conserved in yeast or rodents but is present in some advanced vertebrates
including the primate orthologues, suggesting that this site has arisen more recently and
may induce novel regulatory control on hYVHl function. The Ser335 phosphorylation
site on the other hand is extensively conserved in mammals (including rodents) but is
absent in yeast. Furthermore, the Ser335 phosphorylation site located five amino acids
from the C-terminus resides in a so called SQ site. This consensus sequence is targeted by
members of the phosphatidyl-inositol-3-kinase protein kinase family, including ATM
(ataxia telangiectasia mutated), ATR (ATM and Rad3 related) and DNA-PK (DNAprotein kinase) [32]. Interestingly, under normal cell culture conditions, ATM may
become activated by calyculin A or okadaic acid treatment without the need for DNA
damage [33]. This activity is cell cycle dependent and at a maximum level during G2/M
[34] and upon nocodazole and taxol induced mitotic stress [35]. Thus since both okadaic
acid and calyculinA treatment increased hYVHl phosphorylation, and hYVHl overexpression increased the percentage of cells in G2/M, it will be important to examine if
Ser335 phosphorylation occurs in a G2/M specific manner. Moreover, we are interested in
testing if ATM is the upstream kinase responsible for hYVHl phosphorylation at Ser335.
Our preliminary experiments demonstrated that a JNK inhibitor reduced the
phosphorylation of hYVHl. The third phoshorylation site identified, Thr252, located
within the Zn-binding domain, is a proline directed site, the minimum consensus site for
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JNK. Also, hYVHl has been shown to play a role in protecting cells from various
cellular stresses including hydrogen peroxide, heat stress, and Fas receptor activation
[18]. Since these cellular insults are known JNK activators [36] we are particularly
interested in examining if JNK can directly phosphorylate Thr252.
A large scale experiment targeted at identification of subunits involved in yeast
ribosomal biogenesis (60S pre-ribosomal particles), identified YVHl from Arxl- and
Kre35-TAP tag pull down screens by tandem mass spectrometry [15]. As Arxl displays
nucleoplasm^ and also cytoplasmic localization and Kre35 exhibits cytoplasmic
distribution with nuclear exclusion [15], this is in accordance with herein reported
distribution of Flag-hYVHl. In the 60S ribosomal biogenesis pathway, the early pre-60S
particles are restricted to the nucleolus, the later particles are released into the
nucleoplasm and then exported into cytoplasm [37]. As the nonphosphorylatable N- and
C-terminal mutants displayed predominantly nuclear localization pattern, this suggests a
possibility that the phosphorylation event could be the underlying mechanism required for
loading onto pre-60S prior to nuclear export, thus controlling one of the late maturation
steps in the 60S biogenesis pathway. We are currently investigating if the hYVHl
phosphorylation mutants affect 60S subunit association and the rate of ribosome
biogenesis.
One of the characteristic features observed upon over-expression of the
phosphorylation site mutants was an aberrant nuclear morphology phenotype
accompanied by an increased proportion of cells with an increased DNA content as
detected by flow cytometry. Moreover, knocking down hYVHl expression resulted in the
opposite cell cycle phenotype (increase in Go/Gi) along with an increase in cellular
senescence. Deletion of YVHl in yeast has been associated with slow-growth phenotype
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[9, 11, 12, 16, 17, 24] and a delay in nuclear pre-ribosomal RNA processing, through
impaired nuclear export of 60S subunit [16, 17, 24]. These observations suggest that
hYVHl over-expression may contribute to genomic instability, a hallmark of cancer.
Consistent with this, an increase in DNA copy numbers of the physical location of human
hYVHl at lq [9], has been observed in numerous cancers, including retinoblastoma [38],
liposarcomas [39], and intracranial ependymoma [40]. hYVHl was proposed to be
oncogenic in the latter subset of cancers [40].
The exact mechanism by which hYVHl affects DNA content is still unclear. One
possibility is that hYVHl over-expression forces endoduplication, where cells undergo
repeated rounds of genomic DNA synthesis without an intervening mitosis, producing
polyploid cells [41]. Alternatively, the increased DNA content may reflect a failure of
cytokinesis or uncontrolled DNA replication. It is tempting to speculate, that highly
regulated hYVHl expression is necessary for normal progression through cell cycle, as
both, over-expression and down-regulation, affect cell cycle profiles.
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Conclusions and Future Directions
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In conclusion, the work presented here displays the applicability of MS-based
approaches to various biological systems. This powerful analytical tool was used not only
to identify a novel protein from Artemia franciscana, a model organism for which the
genome sequence is not available (Chapter 2), analyze cysteine modifications on protein
disulfide isomerase due to changes in the redox state (Chapter 3), but also to discover
hYVHl residues modified by phosphorylation (Chapter 4). In each of these cases the data
generated by mass spectrometry provided a valuable and initial step in the quest for the
functional significance of these proteins.
The capability of MS-based approaches to de novo identify a 21 kDA protein from
A. franciscana diapaused embryos as a group 1 LEA protein [1] identified for the first
time the presence of group 1 LEA proteins in animals. Until our discovery, the group 1
LEA proteins were only described for non-animal species [2, 3]. Our observations also
support a role for the group 1 LEA protein in desiccation tolerance in A. franciscana
encysted embryos [1]. As encysted embryos of brine shrimp A. franciscana are one of the
most resistant organisms to withstand extreme environmental conditions, including the
almost complete loss of water [4], our work sheds further light onto molecular
mechanisms governing this process. Furthermore, the sequence assignment to the 21 kDa
protein allowed the generation of antibodies, which have led to the identification of
multiple group 1 LEA proteins in A. franciscana encysted embryos. We have recently
submitted an additional manuscript in this regard.
A combination of an in vitro isotopic labelling technique and MS-based analysis
was employed in order to assess relative changes in the dynamic thiol and disulfide states
of recombinant human protein disulfide isomerase, PDI [5]. ICAT labelling allowed the
monitoring of changes in the redox states of individual cysteine residues within PDI
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under auto-oxidation conditions. As PDI contains four cysteines within two active sites
and two cysteines within the so-called b' domain, ICAT labelling of the active site
cysteines supported previously suggested non-equivalency between these active sites [6,
7]. As the possibility exists, that different environmental stress conditions affect the redox
status and thus activity of PDI, the approach described with minor modifications would
be an invaluable tool in future experiments.
As the major focus of Dr. Vacratsis' laboratory is the study of atypical dual
specificity phosphatases, particularly hYVHl, a more detailed overview of future
experiments regarding this protein is provided.
To our knowledge, the work described herein on the identification and
characterization of hYVHl (DUSP 12) phosphorylation sites, is novel for this family of
proteins. Identification of these sites provides a basis for several lines of future
investigation. For example, one of the next rational steps is to generate phosphospecific
antibodies, which will further facilitate characterization of the functional significance of
these sites. Additionally, cell cycle synchronization experiments, achieved upon drug
treatments, such as double thymidine block for Gi/S, mimosine for Gi and nocodazole for
M phase [8] or by release from double thymidine block, will be a useful approach to
address phosphorylation dependent changes in the localization pattern of hYVHl at the
endogenous level. As hYVHl displays nuclear, perinuclear and cytoplasmic localization
[9-11] a possibility exists, that these localization patterns are cell cycle dependent.
Furthermore, as the identified phosphorylation sites affect the progression through cell
cycle, the use of phosphospecific antibodies will allow the detection of the sub-population
of cells that are phosphorylated at these specific sites by the analysis of their DNA
content by flow cytometry. Last, but not least, the possibility exists, that the
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phosphorylation at these sites might be upregulated in response to stress (and
downregulated by treatment with specific inhibitors) or differentially expressed in
different cell lines. In order to address these possibilities, phosphospecific antibodies are
valuable tools that will allow the determination of relative phosphorylation levels by
western blot analysis of total cellular lysates from cells under various conditions. hYVHl
has also been shown to be overexpressed in chronic myelogenous leukemia [12] and
amplification of the hYVHl gene region has been detected in numerous cancers [13-15].
Thus the use of phosphospecific antibodies in analysis may provide clues as to whether
phosphorylation of these sites is correlated with disease. Furthermore, our results suggest
that several of these sites are important for the generation of DNA content changes in
cells upon hYVHl over-expression. The question is, do they act similarly in
malignancies? This may be in part accomplished by an immunohistochemistry screen of
commercially available core patient biopsies attached onto a microscope slide.
One of the limitations associated with phosphospecific antibodies is their
insufficient performance in immunoprecipitation assays. As there is the possibility, that
phenotypes associated with over-expression of the phosphomutants are caused either by
novel protein-protein interactions or disruption of a critical protein-protein complexes, a
MS-based TAP-tag approach would allow the identification of novel interacting partners.
The TAP-tag method is efficient at the identification of interacting partners at substoichiometric levels [16] and was introduced in detail in Chapter 1. Since overexpression of hYVHl has shown to result in an increased DNA content, wild-type
hYVHl and phosphomimetic S14E and S335E mutants expressed from a TAP-tag vector
will be analyzed in unsynchronized and synchronized cells, as the over-expression has
shown an increase in DNA content. Alternatively, to address the possibility that any of
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the potential interacting partners are hYVHl substrates, an additional mutation of
catalytic aspartic acid to alanine (D84A) will be introduced into these phosphomutants
thus modifying them into "substrate-traps". The "substrate-trap" mutation impedes the
substrate dephosphorylation process. It is noted that while the phosphatase-substrate
complex is still formed, the subsequent cleavage of the thiol phosphate bond initiated by
the nucleophilic cysteine cannot take place without the catalytic acid/base (Asp84), thus
rendering the substrate attached and stable enough to withstand isolation [17]. In order to
reduce the complexity of immunoprecipitated proteins, separation will be performed
either by SDS-PAGE or MudPIT-base method [18] (and introduced in detail in Chapter
1). The latter option has recently become a feasible alternative with the acquisition of a
nano-spray triple quadrupole tandem MS instrument in our laboratory.

The three dimensional structure of proteins, experimentally elucidated either from
x-ray crystallography or NMR studies, provide invaluable insight on how structure
dictates functions. To date, crystal structures of only three atypical DUSPs have been
elucidated, including VHR (DUSP3) [19], JKAP (DUSP22) [20] and VHZ (DUSP23)
[21]. All of these are relatively small proteins and contain only the catalytic domain. As
hYVHl is the only DUSP that contains a phosphatase catalytic domain and a zinc binding
domain, this further complicates calculations for the computational homology model. Dr.
Vacratsis' laboratory is currently in the process of elucidating the x-ray structure of
hYVHl (DUSP12) in collaboration with Dr. B. Crane (Cornell University). One of the
unpredictable properties of proteins is their refractory nature to crystallization, requiring a
long process of optimization. Thus in the meantime, MS-based methods such as the crosslinker MS approach can identify peptides that are spatially close in a folded protein.
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Cross-linked peptides identified from MS-analysis of isotopically labelled crosslinked protein are indicative of the spatial proximity of two linked amino acids at the time
of cross-linking [22, 23]. Upon labelling of intact proteins with a mixture of isotopically
labelled 'heavy' disuccinimidyl suberate (DSS) containing 12 deuteriums (Di2DSS) [23]
and commercially available Tight' D0DSS, cross-linker-modified peptides are detected by
presence of isotopic shift between labelled fragment ion peaks. Experimental evidence
indicated, that DSS formed peptide-peptide links connected mostly lysine residues [22].
After cross-linking the amino acids within the protein and prior to proteolysis, disulfide
bonds were reduced, and thiol groups were alkylated with iodoacetamide. The use of
trypsin to generate peptide fragments has two advantages; first, cleavage does not occur at
the lysine residues participating in the cross-links, thus this miscleavage is included as a
pre-selection criteria; and second, the ability to enrich cross-linked peptide by strong
cation exchange chromatography. Fractionation steps prior to MS-analysis are necessary,
especially in a complex sample, as the cross-linked peptides are present at low
stoichiometry and occur at low frequency compared to unmodified peptides [22]. This
method is applicable to both MALDI [23] and electrospray ionization [22] based MSinstruments. With the latter instrumental set up, the majority of detected cross-linked
peptides have a charge state greater than +3 [22], thus this property can be incorporated
into criteria for inclusion list of peptides selected for MS/MS analysis.
hYVHl contains eleven lysine residues within the catalytic domain and nine
lysine residues within the zinc binding domain, thus with this MS-based approach the
interaction interface between these two domains should be identifiable. If the sensitivity
and detection power of our MALDI-TOF instrument is insufficient for the proposed
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experiments, a nano-spray triple quadrupole mass spectrometer, the newest addition to
our department will be invaluable.
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